<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74658</article-id><article-id pub-id-type="doi">10.7554/eLife.74658</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Discovery of coordinately regulated pathways that provide innate protection against interbacterial antagonism</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-258544"><name><surname>Ting</surname><given-names>See-Yeun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258545"><name><surname>LaCourse</surname><given-names>Kaitlyn D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258546"><name><surname>Ledvina</surname><given-names>Hannah E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258547"><name><surname>Zhang</surname><given-names>Rutan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-207871"><name><surname>Radey</surname><given-names>Matthew C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258548"><name><surname>Kulasekara</surname><given-names>Hemantha D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258549"><name><surname>Somavanshi</surname><given-names>Rahul</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258550"><name><surname>Bertolli</surname><given-names>Savannah K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258551"><name><surname>Gallagher</surname><given-names>Larry A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258552"><name><surname>Kim</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258553"><name><surname>Penewit</surname><given-names>Kelsi M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258554"><name><surname>Salipante</surname><given-names>Stephen J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-224869"><name><surname>Xu</surname><given-names>Libin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1021-5200</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-207866"><name><surname>Peterson</surname><given-names>S Brook</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2648-0965</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21543"><name><surname>Mougous</surname><given-names>Joseph D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5417-4861</contrib-id><email>mougous@uw.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Microbiology, University of Washington School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Medicinal Chemistry, University of Washington School of Pharmacy</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Laboratory Medicine and Pathology, University of Washington School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Biochemistry, University of Washington School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Howard Hughes Medical Institute, University of Washington</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mignot</surname><given-names>Tâm</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS-Aix Marseille University</institution></institution-wrap><country>France</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Harvard T.H. Chan School of Public Health</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>02</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74658</elocation-id><history><date date-type="received" iso-8601-date="2021-10-12"><day>12</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-02-16"><day>16</day><month>02</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-08-23"><day>23</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.22.457286"/></event></pub-history><permissions><copyright-statement>© 2022, Ting et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ting et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74658-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74658-figures-v2.pdf"/><abstract><p>Bacterial survival is fraught with antagonism, including that deriving from viruses and competing bacterial cells. It is now appreciated that bacteria mount complex antiviral responses; however, whether a coordinated defense against bacterial threats is undertaken is not well understood. Previously, we showed that <italic>Pseudomonas aeruginosa</italic> possess a danger-sensing pathway that is a critical fitness determinant during competition against other bacteria. Here, we conducted genome-wide screens in <italic>P. aeruginosa</italic> that reveal three conserved and widespread interbacterial antagonism resistance clusters (<italic>arc1-3</italic>). We find that although <italic>arc1-3</italic> are coordinately activated by the Gac/Rsm danger-sensing system, they function independently and provide idiosyncratic defense capabilities, distinguishing them from general stress response pathways. Our findings demonstrate that Arc3 family proteins provide specific protection against phospholipase toxins by preventing the accumulation of lysophospholipids in a manner distinct from previously characterized membrane repair systems. These findings liken the response of <italic>P. aeruginosa</italic> to bacterial threats to that of eukaryotic innate immunity, wherein threat detection leads to the activation of specialized defense systems.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>interbacterial antagonism</kwd><kwd>innate immunity</kwd><kwd>Tn-seq</kwd><kwd><italic>Pseudomonas aeruginosa</italic></kwd><kwd>toxin</kwd><kwd>phospholipase</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AI080609</award-id><principal-award-recipient><name><surname>Mougous</surname><given-names>Joseph D</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK089507</award-id><principal-award-recipient><name><surname>Salipante</surname><given-names>Stephen J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI136979</award-id><principal-award-recipient><name><surname>Xu</surname><given-names>Libin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>SINGH19R0</award-id><principal-award-recipient><name><surname>Salipante</surname><given-names>Stephen J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>S10OD026741</award-id><principal-award-recipient><name><surname>Salipante</surname><given-names>Stephen J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Mougous</surname><given-names>Joseph D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value><italic>Pseudomonas aeruginosa</italic> defends against interbacterial antagonism through the coordinated expression of previously uncharacterized pathways that grant threat-specific protection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Antagonism from other organisms is a threat faced nearly universally by bacteria living in mixed populations, yet we are only beginning to understand the mechanisms employed in defense against these assaults (<xref ref-type="bibr" rid="bib19">Hersch et al., 2020a</xref>; <xref ref-type="bibr" rid="bib42">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Robitaille et al., 2021</xref>). One defense mechanism that is common in the gut microbiome and potentially other habitats is the production of immunity proteins that grant protection against specific toxins delivered by the type VI secretion system (T6SS) (<xref ref-type="bibr" rid="bib45">Ross et al., 2019</xref>). These ‘orphan’ immunity proteins share homology with and are likely evolved from cognate immunity proteins that protect bacteria from undergoing self-intoxication, which is inherent to the indiscriminate nature of the T6SS delivery mechanism. Core cellular structures have also been implicated in promoting survival during interbacterial antagonism. Extracellular polysaccharide capsules protect <italic>Vibrio cholerae</italic> and <italic>Escherichia coli</italic> from T6SS-based attack of other species (<xref ref-type="bibr" rid="bib20">Hersch et al., 2020b</xref>; <xref ref-type="bibr" rid="bib54">Toska et al., 2018</xref>), and in <italic>Acinetobacter baumannii</italic>, lysine modification at peptidoglycan crosslinks was suggested to render the cell wall resistant to degradation by amidase toxins (<xref ref-type="bibr" rid="bib27">Le et al., 2020</xref>). Finally, characterized stress response pathways also appear to contribute to antagonism defense. Indeed, it has been suggested that bacterial stress responses evolved in part as a means of detecting and responding to antagonistic competitors (<xref ref-type="bibr" rid="bib6">Cornforth and Foster, 2013</xref>; <xref ref-type="bibr" rid="bib35">Lories et al., 2020</xref>). A candidate-based approach applied to <italic>E. coli</italic> and <italic>P. aeruginosa</italic> found that stress response genes involved in envelope integrity and acid stress, among others, can contribute to resistance against a <italic>V. cholerae</italic> phospholipase toxin (<xref ref-type="bibr" rid="bib24">Kamal et al., 2020</xref>). While the <italic>P. aeruginosa</italic> genes identified impacted survival when the toxin was produced heterologously within the organism, they did not influence the fitness of the bacterium during interbacterial competition with <italic>V. cholerae</italic>.</p><p>We previously discovered that <italic>P. aeruginosa</italic> mounts an effective but largely undefined defense upon exposure to an antagonistic competitor, which we named the <italic><bold>P</bold>. <bold>a</bold>eruginosa</italic> <bold>r</bold>esponse to <bold>a</bold>ntagonism (PARA) (<xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref>). The response is activated when a subpopulation of <italic>P. aeruginosa</italic> cells are lysed, releasing intracellular contents that trigger the response in neighboring survivors (<xref ref-type="bibr" rid="bib31">LeRoux et al., 2015b</xref>). PARA is coordinated by the Gac/Rsm global regulatory pathway, which post-transcriptionally controls the expression of nearly 400 genes (<xref ref-type="bibr" rid="bib14">Goodman et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Lapouge et al., 2008</xref>). This regulon includes the Hcp secretion island I-encoded type VI secretion system (H1-T6SS), the activity of which enables <italic>P. aeruginosa</italic> to kill or disable competing bacteria through the delivery of a cocktail of toxic effector proteins (<xref ref-type="bibr" rid="bib22">Hood et al., 2010</xref>). While an important component of PARA, data suggest that the H1-T6SS is just one feature of the response; <italic>P. aeruginosa</italic> strains lacking functionality of the two-component system required to initiate Gac/Rsm signaling are severely crippled in interbacterial antagonism defense relative to those lacking only the H1-T6SS (<xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref>). The majority of the genes under Gac/Rsm control encode proteins of unknown function, and we hypothesized that these could represent uncharacterized, novel mechanisms by which <italic>P. aeruginosa</italic> defends against interbacterial antagonism.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Discovery of coordinately regulated <italic>P. aeruginosa</italic> interbacterial toxin defense pathways</title><p>Prior work by our laboratory has shown that <italic>Burkholderia thailandensis</italic> (<italic>B. thai</italic>) fiercely antagonizes <italic>P. aeruginosa</italic> using its antibacterial T6SS (<xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref>). Thus, to identify its interbacterial defense factors, we subjected a transposon library of <italic>P. aeruginosa</italic> to antagonism by <italic>B. thai</italic> or a derivative lacking antibacterial T6SS activity (ΔT6S) and used high-throughput sequencing to measure gene-level fitness changes. Duplicate screening of this library revealed 34 genes critical for the survival of <italic>P. aeruginosa</italic> specifically while undergoing antagonism by <italic>B. thai</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref> , <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Strikingly, 25 of these belong to the Gac/Rsm regulon and three additional hits included genes directly involved in the Gac/Rsm signaling system (<xref ref-type="bibr" rid="bib14">Goodman et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Lapouge et al., 2008</xref>). Indeed, disruption of genes encoding GacS and GacA, the central sensor kinase and response regulator required for activation of the pathway, respectively, elicited the strongest interbacterial defense defect among all genes in the <italic>P. aeruginosa</italic> genome (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). On the contrary, inactivating insertions in <italic>retS</italic>, encoding a hybrid sensor kinase that negatively regulates GacS, increased interbacterial competitiveness.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Multiple pathways under Gac/Rsm control contribute to <italic>P. aeruginosa</italic> defense against antagonism.</title><p>(<bold>A</bold>) Transposon library sequencing-based comparison of the fitness contribution of individual <italic>P. aeruginosa</italic> genes during growth competition with wild-type <italic>B. thai</italic> versus <italic>B. thai</italic> ∆T6S. Genes under Gac/Rsm control (blue) and those encoding core Gac/Rsm regulatory factors (purple, labeled) are indicated. (<bold>B</bold>) Overview of the Gac/Rsm pathway (SD, Shine–Dalgarno). The <italic>rsmY</italic> and <italic>rsmZ</italic> genes encode small RNA molecules that sequester the translational regulator RsmA. Hybrid sensor kinase PA1611 is here renamed RetS-regulating sensor kinase A (RskA). (<bold>C</bold>) Left: <italic>P. aeruginosa</italic> gene clusters hit (greater than threefold in replicate screens; <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>) in this study. Numbers below genes indicate transposon insertion ratio (<italic>B. thai</italic> ∆T6S/wild-type) for screen in (<bold>A</bold>) followed by the replicate screen (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>); light toned genes were hit in only one replicate. Asterisk indicates genes for which insertion was undetected in libraries obtained from <italic>B. thai</italic> wild-type competition. Right: zoom-in of boxed region of (<bold>A</bold>) with genes colored corresponding to clusters at left. (<bold>D, E</bold>) Recovery of <italic>P. aeruginosa</italic> cells with the indicated genotypes following growth competition against <italic>B. thai</italic> wild-type (<bold>D</bold>) or ∆T6S (<bold>E</bold>). For interbacterial competition assays, the mean ± SD of biological duplicates and associated technical duplicates is shown: *p&lt;0.05 using unpaired two-tailed Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Transposon sequencing-based analysis of <italic>P.</italic> <italic>aeruginosa</italic> fitness determinants during antagonism by <italic>B. thai</italic> compared to <italic>B. thai</italic> with an inactive T6SS (∆<italic>icmF</italic>).</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-74658-fig1-data1-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Multiple pathways under Gac/Rsm control contribute to <italic>P. aeruginosa</italic> defense against antagonism.</title><p>(<bold>A</bold>) Growth of wild-type <italic>P. aeruginosa</italic> in co-culture with the indicated <italic>B. thai</italic> strains. (<bold>B</bold>) Transposon library sequencing-based comparison of the fitness contribution of individual <italic>P. aeruginosa</italic> genes during growth competition with wild-type <italic>B. thai</italic> versus <italic>B. thai</italic> ∆T6S. Genes under Gac/Rsm control (blue) and those encoding core Gac/Rsm regulatory factors (purple, labeled) are indicated. This experiment is a biological replicate of that in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. (<bold>C</bold>) <italic>P. aeruginosa</italic> gene clusters hit (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>) in this study. (<bold>D</bold>) Zoom-in of boxed region of (<bold>B</bold>) with genes colored corresponding to clusters at left. The interbacterial competition assay represents two biological replicates with two associated technical replicates.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Antagonism resistance clusters possess functionally related genes and are in diverse bacteria.</title><p>(<bold>A</bold>) Schematic depicting the <italic>arc1</italic> gene cluster of <italic>P. aeruginosa</italic>. Predicted enzymatic activity of Arc1A, B, D, F is indicated (right) and placed onto a phospholipid biosynthesis pathway (bottom). (<bold>B</bold>) Depiction of <italic>arc2</italic> genes from the indicated species. Genes encoding the predicted MoxR-like ATPase and von Willebrand factor (VWF) domain protein are indicated below the respective genes. Orthologs are colored to highlight synteny. (<bold>C</bold>) Depiction of <italic>arc3</italic> genes from the indicated species. <italic>S. dynata</italic> exemplifies an instance of translational fusion of <italic>arc3A,B</italic>. Domains of unknown function constituting the two proteins are indicated below.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Interbacterial competition assays measure the contribution of <italic>arc1-3</italic> to <italic>P. aeruginosa</italic> fitness during antagonism by <italic>B. thai.</italic></title><p>(<bold>A</bold>) Recovery of <italic>P. aeruginosa</italic> strains bearing the indicated single or double deletions within <italic>arc1-3</italic> following growth competition against wild-type <italic>B. thai</italic>. (<bold>B</bold>) Recovery of <italic>P. aeruginosa</italic> cells with the indicated genotypes following growth competition against wild-type <italic>B. thai</italic>. The mean ± SD of biological duplicates and associated technical duplicates is shown: n.s. corresponds to p&gt;0.05 by unpaired two-tailed Student’s <italic>t</italic>-test. The fold difference in growth yield between mutants and the parental strain is indicated above.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig1-figsupp3-v2.tif"/></fig></fig-group><p>Our screens identified previously uncharacterized genes belonging to three operons under Gac/Rsm control (<xref ref-type="bibr" rid="bib14">Goodman et al., 2004</xref>), several genes within two operons of the HSI-I-encoded T6SS (H1-T6SS) (<xref ref-type="bibr" rid="bib22">Hood et al., 2010</xref>), and two genes within an operon not subject to Gac/Rsm regulation (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Given that false positives are less common among multiple gene hits within an operon, we focused on these genes for subsequent validation in pairwise competition assays. Strains bearing in-frame deletions of the genes most strongly hit in each operon showed substantially reduced fitness in competition with wild-type <italic>B. thai</italic>, and in each instance this could be partially restored by genetic complementation (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Further consistent with our screening results, each of the single-gene deletion mutants grew similarly to the wild-type in competition with <italic>B. thai</italic> unable to antagonize <italic>P. aeruginosa</italic> (<italic>B. thai</italic> ΔT6S) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p></sec><sec id="s2-2"><title>Arc1-3 operate independently and defend in a manner distinct from general stress responses</title><p>The <italic>P. aeruginosa</italic> Gac/Rsm pathway has been implicated in a process we termed danger sensing (<xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref>; <xref ref-type="bibr" rid="bib31">LeRoux et al., 2015b</xref>). We previously showed that the lysis of neighboring kin cells triggers the pathway, leading to T6SS activation. However, the Gac/Rsm pathway post-transcriptionally activates hundreds of genes whose function has largely remained cryptic (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Bioinformatic analyses suggested that each of the uncharacterized Gac/Rsm-regulated operons hit in our screen likely constitute a discrete pathway. Five of the six genes within the PA2536-41 cluster are predicted to encode proteins related to phospholipid biosynthesis or metabolism, including four genes encoding products with significant homology to enzymes required for phosphatidylglycerol synthesis (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Orthologs of core bacterial phospholipid biosynthetic machinery are encoded elsewhere in the genome, indicating likely specialization of this putative pathway. The PA4317-23 genes co-occur across many species within the Xanthomonadaceae and Pseudomonadaceae (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). While none of the proteins encoded by this gene cluster have been characterized, they include a predicted MoxR-like AAA+-ATPase and a protein with a von Willebrand factor (VWF) domain. Related protein pairs co-occur widely and are known to cooperate in a chaperone-like function that releases protein inhibition or stimulates metal cofactor insertion (<xref ref-type="bibr" rid="bib52">Snider and Houry, 2006</xref>; <xref ref-type="bibr" rid="bib55">Tsai et al., 2020</xref>). Finally, PA5113 and PA5114 also co-occur widely, and several organisms encode single polypeptides that represent a fusion of the two proteins (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>).</p><p>Next, we sought to obtain experimental support for our hypothesis that the Gac/Rsm-regulated operons hit in our screen constitute independent functional units. First, we compared the fitness of our single-deletion strains to those bearing in-frame deletions in the two genes most strongly hit within each operon. In each operon, the second deletion did not impact competitiveness with <italic>B. thai</italic>, suggesting that the pairs of genes encode components of the same pathway (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). On the contrary, additive effects on interbacterial competitiveness were observed when genes from each of the three operons were inactivated in a single strain. Indeed, the fitness deficiency of this triple mutant strain approaches that of the ∆<italic>gacS</italic> strain, which lacks Gac/Rsm function entirely (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). Together, these data reveal that the Gac/Rsm pathway and discrete functional units under its control are critical for <italic>P. aeruginosa</italic> survival when antagonized by the T6SS of <italic>B. thai</italic>. Based on these data, we named the genes with the three Gac/Rsm-regulated operons hit in our screen <italic>arc1A-F</italic> (<bold>a</bold>ntagonism <bold>r</bold>esistance <bold>c</bold>luster 1, PA2541-36), <italic>arc2A-G</italic> (PA4317-23), and <italic>arc3A,B</italic> (PA5114-13) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>As a first step toward understanding how Arc1-3 influence the competitiveness of <italic>P. aeruginosa</italic>, we asked whether they serve defensive or offensive roles. In our initial screen, <italic>B. thai</italic> dramatically outnumbered <italic>P. aeruginosa</italic> (~50:1); therefore, the diminished <italic>P. aeruginosa</italic> viability observed under these conditions suggested each pathway can function defensively. However, these conditions do not exclusively isolate the defensive contribution of the pathways. For example, we observed that killing competitor cells via the H1-T6SS indirectly contributes to <italic>P. aeruginosa</italic> viability under these conditions, likely by expanding the available growth niche. To probe the capacity of Arc1-3 to antagonize <italic>B. thai</italic>, we initiated co-culture growth competition assays with an excess of <italic>P. aeruginosa</italic>. We previously demonstrated that in co-cultures initially dominated by <italic>P. aeruginosa,</italic> antagonism by <italic>B. thai</italic> has a negligible impact on <italic>P. aeruginosa</italic> growth (<xref ref-type="bibr" rid="bib49">Schwarz et al., 2010</xref>). Under these conditions, inactivating Arc2 and Arc3 had no impact on <italic>B. thai</italic> survival. Arc1 inactivation led to an increase in <italic>B. thai</italic> survival; however, this effect was modest relative to its impact on <italic>P. aeruginosa</italic> defense (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In contrast, inactivation of the H1-T6SS increased <italic>B. thai</italic> survival by approximately four orders of magnitude, eclipsing its impact on <italic>P. aeruginosa</italic> defense by ~100-fold. Together, these finding indicate that the contributions of Arc1-3 to <italic>P. aeruginosa</italic> competitiveness during antagonism arise predominately from defensive mechanisms.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Arc pathways can provide toxin-specific antagonism defense that eclipses that of other cellular factors.</title><p>(<bold>A</bold>) Recovery of <italic>B. thai</italic> cells following growth competition against a relative abundance of <italic>P. aeruginosa</italic> containing the indicated gene deletions, colored according to <xref ref-type="fig" rid="fig1">Figure 1C</xref>. (<bold>B</bold>) Relative survival of <italic>P. aeruginosa</italic> Arc1-3-inactivated mutants following growth in competition with an excess of the indicated <italic>B. thai</italic> strains (mutant CFU/parental CFU × 100 for each <italic>B. thai</italic> competitor). The loss of ColA or Tle3 activity in <italic>B. thai</italic> increases the relative survival of <italic>P. aeruginosa</italic> lacking Arc2 or Arc3 activity, respectively. (<bold>C, D</bold>) Transposon library sequencing-based comparison of the fitness contribution of individual <italic>P. aeruginosa</italic> genes during growth competition with wild-type <italic>B. thai</italic> versus <italic>B. thai</italic> lacking Tle3 (<bold>C</bold>) or ColA (<bold>D</bold>) activity, colored according to <xref ref-type="fig" rid="fig1">Figure 1C</xref>. Values in parentheses correspond to the number of genes hit (greater than threefold change in transposon insertion frequency) within each cluster compared to the number within each cluster hit in the initial screens (<italic>B. thai</italic> wild-type versus <italic>B. thai</italic> ∆T6S) followed by the average transposon insertion frequency ratio (<italic>B. thai</italic> mutant/<italic>B. thai</italic> wild-type) of the genes in the depicted screen. (<bold>E</bold>) Fitness contribution of each <italic>P. aeruginosa</italic> Arc pathway and the H1-T6SS to defense against Tle3 versus ColA. For interbacterial competition assays, the mean ± SD of biological duplicates and two technical replicates is shown: *p&lt;0.05 using unpaired two-tailed Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Transposon sequencing-based analysis of <italic>P.</italic> <italic>aeruginosa</italic> fitness determinants during antagonism by <italic>B. thai</italic> compared to <italic>B. thai tle3</italic><sup>S264A</sup>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-74658-fig2-data1-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Transposon sequencing-based analysis of <italic>P.</italic> <italic>aeruginosa</italic> fitness determinants during antagonism by <italic>B. thai</italic> compared to <italic>B. thai</italic> ∆<italic>colA</italic>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-74658-fig2-data2-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Arc1-3 do not contribute to the survival of <italic>P. aeruginosa</italic> exposed to common environmental stresses.</title><p>Survival of the indicated <italic>P. aeruginosa</italic> strains during exposure to hydrogen peroxide (50 mM, 30 min) (<bold>A</bold>), high salinity (3 M NaCl, 20 hr) (<bold>B</bold>), high temperature (55°C, 30 min) (<bold>C</bold>), or detergent (0.5% [<italic>w/v</italic>] SDS) (<bold>D</bold>). The mean ± SD of a representative biological replicate with three technical replicates is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Arc1-3 are subject to tight regulation by the Gac/Rsm signaling pathway.</title><p>Anti-VSV-G immunoblot analysis was used to probe the levels of the indicated VSV–G-tagged (–V) Arc proteins encoded at their respective native genomic loci in <italic>P. aeruginosa</italic> wild-type, ∆<italic>retS</italic>, or ∆<italic>gacS</italic> backgrounds. The asterisk denotes a nonspecific VSV-G antibody-reactive band. The arrow highlights the position of Arc2G–V. Blot images are representative of at least two biological replicates. See <xref ref-type="supplementary-material" rid="fig2s2sdata1 fig2s2sdata2 fig2s2sdata3 fig2s2sdata4 fig2s2sdata5 fig2s2sdata6">Figure 2—figure supplement 2—source data 1–6</xref>.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc1A–V.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata2"><label>Figure 2—figure supplement 2—source data 2.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc1A–V RpoB control.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata3"><label>Figure 2—figure supplement 2—source data 3.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc2G–V.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data3-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata4"><label>Figure 2—figure supplement 2—source data 4.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc2G–V RpoB control.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data4-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata5"><label>Figure 2—figure supplement 2—source data 5.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc3A–V.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data5-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata6"><label>Figure 2—figure supplement 2—source data 6.</label><caption><title>Original uncropped image and original uncropped image with relevant bands indicated for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, Arc3A–V RpoB control.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig2-figsupp2-data6-v2.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>The loci encoding Tle1 and Tle3 are duplicated in <italic>B. thai,</italic> and Tle3 induces potent self-intoxication.</title><p>(<bold>A</bold>) Schematic depicting the <italic>tle1</italic>/<italic>tli1</italic> (top) and <italic>tle3</italic>/<italic>tli3</italic> (bottom) loci in the genome <italic>B. thai</italic> E264 strain. Predicted catalytic serine residues mutagenized in this study are indicated by red asterisks. (<bold>B</bold>) Recovery of <italic>B. thai</italic> strain sensitized to Tle3 intoxication (∆<italic>tle3</italic>∆<italic>tli3</italic>) following growth competition against <italic>B. thai</italic> wild-type or a strain in which both orthologs of Tle3 contain an inactivating point mutation. The mean ± SD of two biological replicates with two technical replicates is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Our results suggested that the Gac/Rsm system functions analogously to innate immune sensors of eukaryotic organisms, wherein danger sensing activates the expression of independently functioning downstream effectors that defend the cell against specific threats (<xref ref-type="bibr" rid="bib40">Paludan et al., 2021</xref>). By extension, this response should be distinct from that provoked by general stressors. To test this, we measured the contribution of Arc1-3 to <italic>P. aeruginosa</italic> survival in conditions known to induce general stress response systems, including heat shock, exposure to H<sub>2</sub>O<sub>2</sub>, and propagation in high-salinity media or media containing detergent (<xref ref-type="bibr" rid="bib23">Jørgensen et al., 1999</xref>; <xref ref-type="bibr" rid="bib39">Munguia et al., 2017</xref>). Unlike previously established stress-intolerant control strains (∆<italic>rpoS</italic> and ∆<italic>vacJ</italic>), the survival of strains lacking Arc1-3 function was equivalent to wild-type <italic>P. aeruginosa</italic> in these assays, suggesting that their function is distinct from those involved in general stress resistance (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). This is also in line with the regulatory profile of Arc1-3; immunoblotting showed that basal expression of each is exceedingly low, yet highly inducible through stimulation of the antagonism-responsive Gac/Rsm pathway (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p></sec><sec id="s2-3"><title>Arc1-3 provide defense against distinct threats</title><p>The specific involvement of Arc1-3 in defense against antagonism led us to hypothesize that the pathways could grant protection against mechanistically distinct threats. Notably, <italic>B. thai</italic> delivers a cocktail of toxins to target cells including two predicted phospholipases (Tle1 and Tle3) (<xref ref-type="bibr" rid="bib47">Russell et al., 2013</xref>), a peptidoglycan-degrading amidase (Tae2) and a colicin-like toxin predicted to form inner membrane pores (ColA) (<xref ref-type="bibr" rid="bib46">Russell et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Salomon et al., 2014</xref>). To determine the role of Arc1-3 in defense against insults caused by toxins with biochemically diverse modes of action, we subjected strains with individual Arc pathways inactivated to pairwise competition against <italic>B. thai</italic> strains lacking single toxins in its arsenal. For Tle1 and Tle3, which are duplicated in the <italic>B. thai</italic> genome and required for basal T6SS function, strains bearing mutated codons corresponding to predicted catalytic residues of the proteins were utilized (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Strikingly, we found that Tle3 inactivation abrogated the antagonism defense defect of <italic>P. aeruginosa</italic> lacking Arc3 function (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), whereas its defense defect was maintained in competition experiments against other toxin-inactivated strains of <italic>B. thai</italic>. In contrast, the survival of <italic>P. aeruginosa</italic> lacking Arc2 function was significantly restored by deletion of <italic>colA</italic> in <italic>B. thai</italic>, while none of the single-effector mutations within <italic>B. thai</italic> impacted the defense defect of <italic>P. aeruginosa</italic> lacking Arc1 function. These results support the hypothesis that Arc pathways can afford protection in a manner specific to the damage arising from mechanistically distinct threats (Arc2, Arc3) or play a more general role in defense (Arc1). However, <italic>B. thai</italic> delivers toxins beyond those we inactivated in this study; therefore, we cannot rule out that Arc1 – like Arc2 and Arc3 – provides effector-specific defense.</p><p>We found that Arc2 and Arc3 are major defense factors against insults caused by ColA and Tle3, respectively, suggesting that these toxins may damage cells by a mechanism not efficiently countered by other cellular pathways. To evaluate the relative defensive contribution of Arc2 and Arc3 genome-wide, we performed additional transposon-based screening in which a mutant library of <italic>P. aeruginosa</italic> was grown in competition with <italic>B. thai</italic> strains lacking ColA or Tle3 activity. Remarkably, this experiment defined <italic>arc3A</italic> as the gene most critical for <italic>P. aeruginosa</italic> survival during intoxication by Tle3 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Insertions in the second Arc3 gene, <italic>arc3B</italic>, also crippled <italic>P. aeruginosa</italic> defense against Tle3, though to a lesser degree. Arc2 genes were dispensable for Tle3 defense, and only one gene within Arc1 contributed to Tle3 defense beyond the threefold insertion frequency ratio cutoff we employed. Inactivation of ColA had a relative minor impact on the fitness of most <italic>P. aeruginosa</italic> transposon mutants (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). However, four of the six Arc2 genes hit in our initial screen provided defense against ColA that exceeded our threefold cutoff. Additionally, one Arc1 gene met these criteria, whereas Arc3 genes were wholly dispensable for defense against ColA. These results support the model that Arc3 provides specific defense against Tle3, Arc2 provides a degree of specific protection against ColA, and Arc1 serves a broader role in antagonism defense. A comparison of the fitness contributions of each Arc pathway and the H1-T6SS to <italic>P. aeruginosa</italic> undergoing intoxication by Tle3, ColA or Tle1 highlights the degree of their specificity (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p></sec><sec id="s2-4"><title>Arc3 is a broadly conserved pathway that prevents lysophospholipid accumulation</title><p>The highly specific defense afforded by Arc3 against the predicted phospholipase Tle3 prompted us to further interrogate its function. Arc3A is a large protein containing 35 predicted transmembrane domains and lacking residues strongly indicative of enzymatic activity (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). With predicted outer-membrane-anchored N-terminal lipidation and a C-terminal inner-membrane transmembrane helix, Arc3A is expected to span the periplasm. Neither Arc3A nor Arc3B share significant homology with characterized proteins; however, apparent orthologs of each are encoded by neighboring open-reading frames across an exceptionally wide distribution of bacteria (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Arc3A-related proteins are composed of domain of unknown function 2339 (DUF2339), possess large, yet varying numbers of transmembrane segments, and are found in bacteria belonging to most Gram-negative and Gram-positive phyla. Consistent with the predicted N-terminal localization of Arc3B to the outer membrane, its related proteins are restricted to Gram-negative phyla. Co-immunoprecipitation studies using epitope-tagged variants of Arc3A and Arc3B encoded at their native chromosomal loci provided evidence that the two proteins stably associate (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). The <italic>arc3A</italic> and <italic>arc3B</italic> genes abut a third gene encoded in the same orientation, <italic>estA,</italic> and there is evidence that transcripts containing all three genes are generated by <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="bib12">Gebhardt et al., 2020</xref>). Although <italic>estA</italic> encodes an esterase (<xref ref-type="bibr" rid="bib56">Wilhelm et al., 1999</xref>), which could have relevance for phospholipase defense, <italic>estA</italic> was not detected in our co-immunoprecipitation analyses, it did not exhibit differential insertion frequency in our screens, and in-frame deletion of <italic>estA</italic> did not impact <italic>P. aeruginosa</italic> survival during intoxication by Tle3 (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1 fig2sdata2">Figure 2—source data 1 and 2</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Arc3B is a predicted massive polytopic membrane protein with functionally complementing family members that occur widely in Gram-negative and -positive bacterial phyla.</title><p>(<bold>A</bold>) Schematic depiction of Arc3A and Arc3B based on bioinformatic predictions. (<bold>B</bold>) Phylogeny of bacterial phyla with representative <italic>arc</italic> genes depicted and colored as in (<bold>A</bold>). Membrane-associated regions (grayed) and the number of predicted transmembrane segments are indicated. (<bold>C</bold>) Recovery of <italic>P. aeruginosa</italic> strains bearing the indicated mutations and containing a control chromosomal insertion (–) or insertion constructs expressing Arc3B proteins derived from assorted bacteria (<italic>P. aer</italic>, <italic>P. aeruginosa; P. pro</italic>, <italic>P. protegens; B. cen</italic>, <italic>B. cenocepacia; P. syr</italic>, <italic>P. syringae; C. rod</italic>, <italic>Citrobacter rodentium</italic>) following growth competition against <italic>B. thai</italic> wild-type. (<bold>D</bold>) Recovery of the indicated <italic>P. protegens</italic> strains following growth competition against <italic>B. thai</italic> wild-type or a strain lacking Tle3 activity. For interbacterial competition assays, the mean ± SD of biological duplicates and two or three associated technical replicates is shown: *p&lt;0.05 using unpaired two-tailed Student’s <italic>t</italic>-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>EstA and Arc3B inactivation does not significantly impact <italic>P. aeruginosa</italic> fitness in pairwise growth competition experiments with <italic>B. thai</italic>.</title><p>Recovery of the indicated <italic>P. aeruginosa</italic> strains following growth in competition with <italic>B. thai</italic> wild-type or a strain lacking Tle3 activity (<italic>tle3<sup>S264A</sup></italic>). Means ± SD of biological duplicates with three technical replicates s shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig3-figsupp1-v2.tif"/></fig></fig-group><p>The observation that Arc3A proteins are found in bacteria lacking an Arc3B homolog, combined with our finding that Arc3B contributes relatively little to Tle3 defense, led us to speculate that Arc3A plays an intrinsic role in defense, independent of its interaction Arc3B. We tested this by examining the ability of Arc3A-related proteins from other species to complement the defense defect of <italic>P. aeruginosa</italic> Δ<italic>arc3A</italic>. Despite high-sequence divergence that would likely preclude specific interactions with Arc3B or other <italic>P. aeruginosa</italic> factors, four of these proteins restored Tle3 defense to a statistically significant degree and two provided protection equivalent to that of <italic>P. aeruginosa arc3A</italic> expressed in the same manner (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We also examined one of these proteins in its native context. Inactivation of <italic>arc3A</italic> in <italic>Pseudomonas protegens</italic> conferred a strong interbacterial antagonism defense defect specific to <italic>B. thai</italic> Tle3 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In total, these data strongly suggest that proteins in the Arc3A family possess the intrinsic capacity to protect bacteria against Tle3-like toxins, and potentially phospholipase toxins more broadly.</p><p>While the ability of heterologously expressed Arc3A homologs to contribute to <italic>P. aeruginosa</italic> defense demonstrates that these proteins can function independently, this finding does not rule out the possibility that in <italic>P. aeruginosa</italic> Arc3B enhances the defensive function of Arc3A. In two of our Tn-seq screens (<xref ref-type="fig" rid="fig1">Figure 1A and C</xref>, <xref ref-type="fig" rid="fig2">Figure 2C</xref>), we observed a significant difference in <italic>arc3B</italic> insertion frequency during competition with wild-type <italic>B. thai</italic> compared to the T6SS- or Tle3-inactivated mutants. However, in pairwise competition experiments with <italic>B. thai,</italic> we were unable to detect a significant fitness defect associated with <italic>arc3B</italic> inactivation in either the wild-type or the Δ<italic>arc3A</italic> background (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). These results suggest that Arc3B may play an auxiliary role in defense that is only detectable under the more stringent conditions of the Tn-seq screens, where <italic>P. aeruginosa</italic> strains compete with each other as well as <italic>B. thai</italic>.</p><p>Enzymes with PLA activity cleave glycerophospholipids at the <italic>sn1</italic> or <italic>sn2</italic> position, generating fatty acid and detergent-like lysophospholipid products (<xref ref-type="bibr" rid="bib8">Filkin et al., 2020</xref>). For toxins like Tle3, which are delivered to target cells in exceedingly low quantities (<xref ref-type="bibr" rid="bib10">Fridman et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Hernandez et al., 2020</xref>), it is likely toxic products, rather than phospholipid depletion per se, that most immediately contribute to cell death. Based on the intrinsic capacity of Arc3A to grant protection against Tle3, a predicted PLA, we hypothesized that it directly mitigates damage caused by the toxic products of Tle3. To test this, we measured phospholipid content within extracts derived from competing <italic>P. aeruginosa</italic> and <italic>B. thai</italic> strains at a time point immediately prior to detectable changes in <italic>P. aeruginosa</italic> viability. Strikingly, relative to mixtures containing the wild-type organisms, those containing <italic>P. aeruginosa</italic> ∆<italic>arc3A</italic> possessed highly elevated levels of lysophosphatidylethanolamine (LPE) and monolysocardiolipin (MLCL) in a manner dependent on the activity of Tle3 in <italic>B. thai</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Lysophosphatidylglycerol, free fatty acid, and corresponding parent phospholipid levels were not measurably altered by Tle3 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Arc3 prohibits Tle3-catalyzed lysophospholipid accumulation by a mechanism distinct from known pathways.</title><p>(<bold>A–D</bold>) Mass spectrometric (<bold>A</bold>) and radiographic thin layer chromatography (TLC) (<bold>B</bold>) analysis of major phospholipid and lysophospholipid species within lipid extracts derived from the indicated mixtures of <italic>P. aeruginosa</italic> and <italic>B. thai</italic> strains. <italic>P. aeruginosa</italic> were grown in <sup>32</sup>PO<sub>4</sub><sup>2-</sup> prior to incubation with <italic>B. thai</italic>. Strains were allowed to interact for 1 hr before phospholipids were harvested. Radiolabeled molecules of interest within biological triplicate experiments resolved by TLC were quantified by densitometry (<bold>C, D</bold>) (<bold>E</bold>) Mass spectrometric analysis of major phospholipid and lysophospholipid species within lipid extracts derived from mixtures containing <italic>B. thai</italic> lacking Tle3-specific immunity factors competing with the indicated <italic>B. thai</italic> strains. (<bold>F</bold>) Recovery of the indicated <italic>P. aeruginosa</italic> strains following growth competition against <italic>B. thai</italic> wild-type or a strain lacking Tle3 activity. (<bold>G</bold>) Radiographic TLC analysis of products extracted after incubation of <italic>P. aeruginosa</italic>-derived spheroplasts with purified radiolabeled lysophosphatidylethanolamine (LPE). For interbacterial competition assays, the mean ± SD of biological replicates and associated technical replicates is shown: *p&lt;0.05 using unpaired two-tailed Student’s <italic>t</italic>-test. TLC images shown are representative of at least two biological replicates. See also <xref ref-type="supplementary-material" rid="fig4sdata1 fig4sdata2 fig4sdata3">Figure 4—source data 1–3</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original uncropped image and original uncropped image with relevant spots indicated for <xref ref-type="fig" rid="fig4">Figure 4B</xref>, left TLC.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig4-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Original uncropped image and original uncropped image with relevant spots indicated for <xref ref-type="fig" rid="fig4">Figure 4B</xref>, right TLC.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig4-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Original uncropped image and original uncropped image with relevant spots indicated for <xref ref-type="fig" rid="fig4">Figure 4G</xref>, right TLC.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-74658-fig4-data3-v2.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Tle3 intoxication does not impact free fatty acids nor intact parent phospholipids in <italic>P. aeruginosa</italic>.</title><p>Mass spectrometric analysis of free fatty acid (<bold>A</bold>) and parent phospholipid species (<bold>B</bold>) within lipid extracts derived from the indicated mixtures. Data represent the mean ± SD of biological duplicates with two technical replicates.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title><italic>Arc3B</italic> genes are encoded adjacent to <italic>aas</italic> genes in diverse bacteria.</title><p>Schematic depicting <italic>arc3B</italic> and <italic>aas</italic> loci in the indicated bacterial species.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Overexpression of <italic>aas</italic> fails to complement the competitive defect associated with Arc3A inactivation.</title><p>Recovery of the indicated <italic>P. aeruginosa</italic> strains carrying empty pPSV39 (control) or pPSV39-<italic>aas</italic> grown in competition with an excess of <italic>B. thai</italic> with Isopropyl β-D-1-thiogalactopyranoside (IPTG) for induction of expression from the plasmid. Data represent mean and standard deviation from technical duplicates from one biological replicate representative of two conducted.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-fig4-figsupp3-v2.tif"/></fig></fig-group><p>The accumulated lysophospholipids we observed could derive from <italic>P. aeruginosa</italic> or they could result from retaliatory activity against <italic>B. thai</italic>. To distinguish these possibilities, we subjected <italic>P. aeruginosa</italic> strains with radiolabeled phospholipids to Tle3 intoxication by unlabeled <italic>B. thai</italic> strains. Radiographic TLC analysis of the phospholipids generated in these strain competition mixtures confirmed that <italic>P. aeruginosa</italic> lacking Arc3B accumulates LPE and MLCL during Tle3 intoxication (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>). Tle3 belongs to a family of effectors for which there remains no definitively characterized member. We were unable to measure the activity of the enzyme in vitro; thus, to determine whether the accumulation of LPE and MLCL were a direct result of Tle3 activity, we quantified phospholipids in extracts derived from <italic>B. thai</italic> strains undergoing Tle3-based self-intoxication (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Samples derived from mixtures composed of a <italic>B. thai</italic> strain with Tle3 and a derivative strain sensitized to Tle3 intoxication through cognate immunity gene inactivation accumulated LPE and MLCL, mirroring our interspecies competition findings (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><p>In <italic>E. coli</italic>, lysophospholipids are transported across the inner membrane by the dedicated transporter LplT, after which they are reacylated by Aas (<xref ref-type="bibr" rid="bib58">Zheng et al., 2017</xref>). Both LplT and Aas have been shown to play a critical role in defending <italic>E. coli</italic> cells from phospholipase attack (<xref ref-type="bibr" rid="bib32">Lin et al., 2018</xref>). In <italic>P. aeruginosa,</italic> LplT and the acylation domain of Aas are found in a single predicted polypeptide, encoded by PA3267 (<italic>aas</italic>). Interestingly, the <italic>aas</italic> gene was illuminated as a potential <italic>P. aeruginosa</italic> antagonism defense factor in two of the transposon mutant screens we performed and <italic>aas</italic> genes neighbor <italic>arc3</italic> genes in many bacteria (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). In pairwise interbacterial competition assays, we were unable to detect the impact of <italic>aas</italic> inactivation on <italic>P. aeruginosa</italic> fitness; however, we found that <italic>P. aeruginosa</italic> strains lacking both <italic>aas</italic> and <italic>arc3A</italic> exhibited a Tle3 defense defect substantially greater than that associated with Arc3A inactivation alone (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Aas overexpression complements the Δ<italic>aas-</italic>dependent defect in this strain, but it does not compensate for the inactivation of Arc3A (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). Additionally, we found that Aas is required for PE regeneration from LPE, whereas Arc3A neither contributed to this process, nor could we detect changes in LPE stability upon Arc3A inactivation in the absence of antagonism (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). These findings indicate that <italic>arc3</italic> encodes a previously undescribed, widespread and independent pathway that prohibits lysophospholipid accumulation by an interbacterial phospholipase toxin.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Evidence suggests that the existence of bacteria is characterized by an onslaught of challenges to their integrity (<xref ref-type="bibr" rid="bib15">Granato et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Peterson et al., 2020</xref>). This is borne out in part by recent work in the phage arena, which has highlighted a vast number of dedicated bacterial defense systems against these parasites (<xref ref-type="bibr" rid="bib1">Bernheim and Sorek, 2020</xref>; <xref ref-type="bibr" rid="bib16">Hampton et al., 2020</xref>). It is now appreciated that the amalgam of these systems constitutes a bacterial immune system, with both innate and adaptive arms that are functionally analogous, and even evolutionarily related to those of eukaryotic organisms (<xref ref-type="bibr" rid="bib37">Morehouse et al., 2020</xref>). Our work shows that bacteria also possess a multitude of coordinately regulated pathways that provide defense against the threats posed by other bacteria. This further cements the analogy between the immune systems of bacterial and eukaryotic cells, the latter of which also rely on the coordinated production of factors specialized for countering threats of viral or bacterial origin.</p><p>We found that Arc3A is the single cellular factor of <italic>P. aeruginosa</italic> most critical for defense against a PLA toxin. Whether Arc3A, perhaps in concert with Arc3B, offers a wider breadth of defensive activity is not known. However, it is notable that phospholipase toxins are ancient and among the most prevalent bacterial toxins known. Even in the absence of direct antagonism by a PLA toxin, environmental lysophospholipids and those generated during normal cellular processes may represent ongoing threats to bacterial viability (<xref ref-type="bibr" rid="bib9">Flores-Díaz et al., 2016</xref>). We observed low Arc3A expression in the absence of Gac/Rsm activation, arguing that its role in PARA serves an adaptive purpose.</p><p>The precise mechanism by which Arc3 proteins defend against intoxication by phospholipase toxins remains unknown. Although we found that Arc3 grants specific protection against Tle3, the relatively low levels of <italic>P. aeruginosa</italic> intoxication achieved by Tle1 do not permit us to rule out that it might also provide broader phospholipase defense. The number and density of transmembrane helices in Arc3A family proteins is unusual, and we postulate that these anomalous features of the protein are intimately connected to its mechanism of action. These segments may sequester lysophospholipids and facilitate their turnover or it is conceivable that they directly recruit and interfere with phospholipase enzymes.</p><p>We have found that several previously uncharacterized gene clusters under Gac/Rsm control contribute critically to PARA. Our bioinformatic analyses show that the <italic>arc</italic> clusters are widely conserved among Bacteria, yet the Gac/Rsm pathway is restricted to γ-Proteobacteria. If <italic>arc</italic> genes play similar roles in these diverse bacteria, which our data suggest, their expression is also likely subject to induction by antagonism. It will be of interest in future studies to probe the generality of coordinated interbacterial defenses by identifying additional signaling systems responsive to antagonism. Collectively, our findings provide new insight into the diversity of mechanisms bacteria have evolved to defend against interbacterial attack and suggest that many more cryptic specialized defense pathways await discovery.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Bacterial strains and culture conditions</title><p>A detailed list of all strains and plasmids used in this study can be found in Appendix 2—key resources table. Bacterial strains under investigation in this study were derived from <italic>P. aeruginosa</italic> PAO1, <italic>B. thai</italic> E264, and <italic>P.protegens</italic> pf-5 (<xref ref-type="bibr" rid="bib41">Paulsen et al., 2005</xref>; <xref ref-type="bibr" rid="bib53">Stover et al., 2000</xref>; <xref ref-type="bibr" rid="bib57">Yu et al., 2006</xref>). All strains were grown in Luria-Bertani (LB) broth and incubated either at 37°C (<italic>P. aeruginosa</italic> and <italic>B. thai</italic>) or 30°C (<italic>P. protegens</italic>). For <italic>Pseudomonas</italic> strains, the media was supplemented with 25 μg/ml irgasan, 15 μg/ml gentamicin, 5% (<italic>w/v</italic>) sucrose, and 0.2% (<italic>w/v</italic>) arabinose as needed. <italic>B. thai</italic> was cultured with 15 μg/ml gentamicin and 200 μg/ml trimethoprim as necessary, and counterselection for allelic exchange was performed on M9 minimal medium agar plate containing 0.4% (<italic>w/v</italic>) glucose and 0.2% (<italic>w/v</italic>) <italic>p</italic>-chlorophenylalanine. <italic>E. coli</italic> strains used in this study included DH5α for plasmid maintenance, SM10 for conjugal transfer of plasmids into <italic>P. aeruginosa</italic>, <italic>P. protegens</italic>, and <italic>B. thai,</italic> and UE54 for radiolabeled phosphatidylethanolamine (PE) synthesis. <italic>E. coli</italic> strains were grown in LB supplemented with 15 μg/ml gentamicin, 150 μg/ml carbenicillin, and 200 μg/ml trimethoprim as needed.</p></sec><sec id="s4-2"><title>Plasmid construction</title><p>All primers used in plasmid construction and generation of mutant strains are listed in <xref ref-type="table" rid="app3table1">Appendix 3—table 1</xref>. In-frame chromosomal deletions and point mutations were created using the suicide vector pEXG2 for <italic>P. aeruginosa</italic> and <italic>P. protegens</italic>, and pJRC115 for <italic>B. thai</italic> (<xref ref-type="bibr" rid="bib3">Chandler et al., 2009</xref>; <xref ref-type="bibr" rid="bib43">Rietsch et al., 2005</xref>). For the generation of chromosomal mutation constructs, 750 bp regions flanking the mutation site were PCR amplified and inserted stitched together into the appropriate vector via Gibson assembly (<xref ref-type="bibr" rid="bib13">Gibson et al., 2009</xref>). Site-specific chromosomal insertions in <italic>P. aeruginosa</italic> were generated using pUC18-Tn7t-pBAD-araE as previously described (<xref ref-type="bibr" rid="bib21">Hoang et al., 2000</xref>). Our trimethoprim-resistant <italic>B. thai</italic> strain was generated using pUC18T-mini-Tn7-Tp-PS12-mCherry via the mini-Tn7 system (<xref ref-type="bibr" rid="bib29">LeRoux et al., 2012</xref>).</p></sec><sec id="s4-3"><title>Generation of mutant strains</title><p>For <italic>P. aeruginosa</italic> and <italic>P. protegens</italic> strain generation, pEXG2 mutation constructs were transformed into <italic>E. coli</italic> SM10, and SM10 donors were subsequently mixed and incubated together with <italic>Pseudomonas</italic> recipients on a nitrocellulose membrane on top of an LB agar plate at a ratio of 10:1 donor–recipient. The cell mixtures were incubated for 6 hr at 37°C to allow for conjugation. These cell mixtures were then scraped up, resuspended into 200 μl LB, and plated on LB agar plates containing irgasan and gentamicin to select for cells containing the mutant construct inserted into the chromosome. <italic>Pseudomonas</italic> merodiploid strains were then grown overnight in nonselective LB media, followed by counterselection on LB no-salt agar plates supplemented with sucrose. Gentamicin-sensitive, sucrose-resistant colonies were screened for allelic replacement by colony PCR, and mutations were confirmed via Sanger sequencing of PCR products.</p><p>For <italic>B. thai</italic> strain generation, pJRC115 mutation constructs were transformed into <italic>E. coli</italic> SM10. Conjugation to enable plasmid transfer was performed as described above and plated on LB agar containing gentamicin and trimethoprim to select for <italic>B. thai</italic> with the chromosomally integrated plasmid. Merodiploids were grown overnight in LB media at 37°C, then plated on M9 minimal medium containing <italic>p</italic>-chlorophenylalanine for counterselection. Trimethoprim-sensitive, <italic>p</italic>-chlorophenylalanine-resistant colonies were screened for allelic replacement by colony PCR, and mutations were confirmed via Sanger sequencing of PCR products.</p><p>For expression of Arc1F, Arc2G, Arc3A, and Arc3A-homologs in <italic>P. aeruginosa</italic>, pUC18-Tn7t-pBAD-araE containing the gene of interest and the helper plasmid pTNS3 were co-transformed into <italic>P. aeruginosa</italic> strains by electroporation (<xref ref-type="bibr" rid="bib5">Choi et al., 2008</xref>). After 6 hr of outgrowth in LB at 37°C, transformants were plated on an LB agar plate with gentamicin to select for cells with mini-Tn7 integration.</p></sec><sec id="s4-4"><title>Bacterial competition assay</title><p>For each co-culture competition experiment, donor and recipient strains were first grown for 20 hr in LB medium. Cultures were spun for 1 min at 20,000 × <italic>g</italic> to pellet cells, the supernatant removed, and cells were washed once with fresh LB medium. Cell pellets were resuspended in LB and normalized to OD<sub>600</sub> = 20. Mixtures of donor and recipient strains were then established at 20:1 (<italic>B. thai</italic> vs. <italic>P. aeruginosa, P. protegens,</italic> or <italic>B. thai</italic>) or 10:1 (<italic>P. aeruginosa</italic> vs. <italic>B. thai</italic>) <italic>v/v</italic> ratios. The initial ratios of donor and recipient strains in these mixtures were measured by performing 10-fold serial dilutions and plating on appropriate selective media to evaluate by colony-forming unit (CFU) analysis. The co-culture competitions were initiated by spotting 5 µl of each mixture onto nitrocellulose filters placed on 3% (<italic>w/v</italic>) agar LB no-salt plates supplemented with L-arabinose for induction of gene expression as necessary. Competitions were incubated for 6 hr at 37°C between <italic>B. thai</italic> and <italic>P. aeruginosa</italic>, or 6 hr at 30°C for competition between <italic>B. thai</italic> and <italic>P. protegens</italic>. For <italic>B. thai</italic> self-intoxication, competitions were incubated at 37°C for 3 hr. Cells were harvested by scraping individual spots from excised sections of the nitrocellulose filter into LB medium. Suspensions were serially diluted and plated on selective media for CFU quantification.</p></sec><sec id="s4-5"><title>Immunoblotting analysis</title><p>To analyze the expression of Arc1F-VSV-G, Arc2G-VSV-G, and Arc3A-VSV-G, <italic>P. aeruginosa</italic> strains were grown in LB broth at 37°C to log phase. Cells were pelleted and resuspended in lysis buffer (20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% [<italic>v/v</italic>] glycerol) and then mixed 1:1 with 2X SDS-PAGE sample loading buffer. Samples were then boiled at 100°C for 10 min and loaded at equal volumes to resolve using SDS-PAGE, then transferred to nitrocellulose membranes. Membranes were blocked in TBST (10 mM Tris-HCl pH 7.5, 150 mM NaCl, and 0.1% [<italic>w/v</italic>] Tween-20) with 5% (<italic>w/v</italic>) non-fat milk for 30 min at room temperature, followed by incubation with anti-VSV-G or with anti-ribosome polymerase β subunit primary antibodies diluted in TBST for 1 hr at room temperature on an orbital shaker. Blots were then washed with TBST, followed by incubation with secondary antibody (goat anti-rabbit or anti-mouse HRP conjugated) diluted in TBST for 30 min at room temperature. Finally, blots were washed with TBST again and developed using Radiance HRP substrate and visualized using iBright imager.</p></sec><sec id="s4-6"><title>Lipidomic analysis</title><p>To analyze lipid content after intra- and inter-species intoxication, overnight cultures of donor and recipient cells were harvested and mixed at 1:1 (<italic>v/v</italic>) ratio in LB medium. These mixtures were spotted onto a 3% (<italic>w/v</italic>) agar LB no-salt plate and incubated for 1 hr at 37°C to allow for intoxication. Cells were then collected, and the lipids were extracted using the Bligh–Dyer method (<xref ref-type="bibr" rid="bib2">Bligh and Dyer, 1959</xref>). Briefly, bacterial pellets were resuspended in 0.5 ml of solution containing 0.5 M NaCl in 0.5 N HCl, followed by adding 1.5 ml of chloroform/methanol mixture (1:2, <italic>v/v</italic>). Suspensions were vortexed at room temperature for 15 min, 1.5 ml of 0.5 M NaCl in 0.5 N HCl solution was added to each sample, and vortexed for an additional 5 min. Lipid and aqueous layers were separated by centrifugation at 2000 × <italic>g</italic> for 5 min. The lower lipid phase was collected, and these dried lipid samples were analyzed for PE, PG, CL, LPE, LPG, and MLCL content by the Kansas State Lipidomics Research Center.</p><p>Lipid samples were analyzed by electrospray ionization triple quadrupole mass spectrometry in direct infusion mode, and data were processed as described by with slight modifications (<xref ref-type="bibr" rid="bib50">Shiva et al., 2013</xref>), which include use of a Waters Xevo TQS mass spectrometer (Milford, MA). Internal standards used to normalize data are shown in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>. For PE and LPE, SPLASH standards were used for normalization (Avanti Polar Lipids, Alabaster, AL). Mass spectrometry global parameters, scan modes, and data processing parameters are shown in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>.</p></sec><sec id="s4-7"><title>Proteomic analysis</title><p><italic>P. aeruginosa</italic> strains containing VSV-G-tagged proteins were grown in 50 ml to mid-log phase, centrifuged at 2500 × <italic>g</italic> for 15 min, and the pellets harvested by resuspension in lysis buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5% [<italic>w/v</italic>] glycerol, 0.5% [<italic>v/v</italic>] Triton X-100). Cell lysates were prepared by sonication, and tagged proteins were enriched by incubating cell lysates with 30 μl of anti-VSV-G agarose beads at 4°C for 4 hr with constant rotation. Agarose beads were then pelleted by centrifugation at 100 × <italic>g</italic> for 2 min and washed three times with 20 mM ammonium bicarbonate. VSV-G agarose beads and bound proteins were then treated with 10 μl of 10 ng/μl (100 ng total per sample) sequencing grade trypsin for 16 hr at 37°C. After digestion, 40 μl of 20 mM ammonium bicarbonate was added to the agarose beads and peptide mixture and lightly mixed. Beads were centrifuged at 300 × <italic>g</italic> for 3 min, and the supernatant collected as the peptide fraction. This peptide mixture was reduced with 5 mM Tris(2-carboxyethyl) phosphine hydrochloride for 1 hr, followed by alkylation using 14 mM iodoacetamide for 30 min in the dark at room temperature. Alkylation reactions were quenched using 5 mM 1,4-dithiothreitol. Samples were then diluted with 100% acetonitrile (ACN) and 10% (<italic>w/v</italic>) trifluoroacetic acid (TFA) to a final concentration of 5% ACN (<italic>v/v</italic>) and 0.5% TFA (<italic>w/v</italic>) and applied to MacroSpin C18 columns (30 μg capacity) that had been charged with 100% ACN and ddH<sub>2</sub>O. Bound peptides were then washed twice in 5% (<italic>v/v</italic>) ACN and 0.5% (<italic>w/v</italic>) TFA, before elution with 70% (<italic>v/v</italic>) ACN and 0.1% (<italic>v/v</italic>) formic acid (FA).</p><p>Peptides were analyzed by LC-MS/MS using a Dionex UltiMate 3000 Rapid Separation nanoLC and a Q Exactive HF Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific Inc, San Jose, CA). Approximately 1 μg of peptide samples was loaded onto the trap column, which was 150 μm × 3 cm in-house packed with 3 μm C18 beads. The analytical column was a 75 μm × 10.5 cm PicoChip column packed with 3 μm C18 beads (New Objective, Inc, Woburn, MA). The flow rate was kept at 300 nl/min. Solvent A was 0.1% FA in water and Solvent B was 0.1% FA in ACN. The peptide was separated on a 120 min analytical gradient from 5% ACN/0.1% FA to 40% ACN/0.1% FA. The mass spectrometer was operated in data-dependent mode. The source voltage was 2.10 kV, and the capillary temperature was 320°C. MS 1 scans were acquired from 300 to 2000 <italic>m/z</italic> at 60,000 resolving power and automatic gain control (AGC) set to 3 × 10<sup>6</sup>. The top 15 most abundant precursor ions in each MS 1 scan were selected for fragmentation. Precursors were selected with an isolation width of 2 Da and fragmented by higher-energy collisional dissociation (HCD) at 30% normalized collision energy in the HCD cell. Previously selected ions were dynamically excluded from re-selection for 20 s. The MS 2 AGC was set to 1 × 10<sup>5</sup>.</p><p>Proteins were identified from the tandem mass spectra extracted by Xcalibur version 4.0. MS/MS spectra were searched against the Uniprot <italic>P. aeruginosa</italic> PAO1 strain database using Mascot search engine (Matrix Science, London, UK; version 2.5.1). The MS 1 precursor mass tolerance was set to 10 ppm, and the MS 2 tolerance was set to 0.05 Da. A 1% false discovery rate cutoff was applied at the peptide level. Only proteins with a minimum of two unique peptides above the cutoff were considered for further study. The search result was visualized by Scaffold (version 4.8.3, Proteome Software, Inc, Portland, OR).</p></sec><sec id="s4-8"><title>Transposon mutant library construction</title><p>A <italic>P. aeruginosa</italic> PAO1 transposon mutant library of ~80,000 unique Himar1 insertions was prepared using established protocols (<xref ref-type="bibr" rid="bib28">Lee et al., 2017</xref>). Briefly, <italic>P. aeruginosa</italic> were mutagenized by delivery of the transposon- and transposase-bearing suicide vector pBT20 from <italic>E. coli</italic> SM10 λpir (<xref ref-type="bibr" rid="bib25">Kulasekara et al., 2005</xref>). Insertion mutants were selected on LB agar containing irgasan and gentamycin and pooled. The library was harvested and transposon insertion sites of the complete pool were defined by transposon insertion sequencing as described below.</p></sec><sec id="s4-9"><title>Transposon mutant library screen in bacterial competition</title><p>The <italic>P. aeruginosa</italic> transposon mutant library was grown at 37°C to mid-log phase. Cell suspensions were then normalized to OD<sub>600</sub> = 1 and incubated with 100 OD<sub>600</sub> of <italic>B. thai</italic> donor strains (wild-type, ∆<italic>icmF</italic>, <italic>tle3</italic><sup>S264A</sup>, or ∆<italic>colA</italic>). Competitions were performed on 3% (<italic>w/v</italic>) agar LB no-salt plates at 37°C for 7 hr. Cells were washed once with PBS, diluted, and plated on LB agar plates supplemented with irgasan to select for viable <italic>P. aeruginosa</italic> cells. After overnight incubation, cells were harvested, and genomic DNA was directly extracted from pellets using QIAGEN Blood and Tissue Midi gDNA prep kit. Transposon insertion sequencing libraries were generated from 3 µg gDNA per sample using the C-tailing method as described (<xref ref-type="bibr" rid="bib11">Gallagher, 2019</xref>) with the transposon-specific primers listed in <xref ref-type="table" rid="app3table1">Appendix 3—table 1</xref>. For PCR round 1, PCR_1A and PCR_1B were used. For PCR round 2, PCR_2A, PCR_2B, and PCR_2C were used. For sequencing, Seq_primer was used. Libraries were pooled and sequenced in multiplex using an Illumina MiSeq with a 5% PhiX spike-in.</p></sec><sec id="s4-10"><title>Tn-seq data analysis</title><p>Seqmagick was used to trim the first six bases from each read (<ext-link ext-link-type="uri" xlink:href="https://github.com/fhcrc/seqmagick">https://github.com/fhcrc/seqmagick</ext-link>; <xref ref-type="bibr" rid="bib36">Matsen Group, 2020</xref>). Reads were then aligned, and counts were enumerated using TRANSIT TPP (<ext-link ext-link-type="uri" xlink:href="https://transit.readthedocs.io/en/latest/tpp.html">https://transit.readthedocs.io/en/latest/tpp.html</ext-link>). An annotation GFF was created from the original <italic>P. aeruginosa</italic> PAO1 GFF file (GCF_000006765.1) and was translated to TRANSIT portable format using the TRANSIT 'convert gff_to_prot_table' command (<ext-link ext-link-type="uri" xlink:href="https://transit.readthedocs.io/en/latest/transit_running.html#prot-tables-annotations">https://transit.readthedocs.io/en/latest/transit_running.html#prot-tables-annotations</ext-link>). Finally, the TRANSIT 'export combined_wig' command was used to combine and annotate the counts. <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref> provides summary data of the sequencing runs and their processing by TRANSIT.</p></sec><sec id="s4-11"><title>Bioinformatic analysis of Arc3 gene distribution</title><p>The phylogenetic profiler tool in IMG (<xref ref-type="bibr" rid="bib4">Chen et al., 2021</xref>) was used to determine the distribution of Arc3A homologs (identified as proteins classified under the Pfam 10101) across bacterial phyla. The number and location of predicted transmembrane domains present in representative Arc3A homologs from each phylum were calculated using CCTOP and TMpred (<ext-link ext-link-type="uri" xlink:href="https://embnet.vital-it.ch/software/TMPRED_form.html">https://embnet.vital-it.ch/software/TMPRED_form.html</ext-link>) (<xref ref-type="bibr" rid="bib7">Dobson et al., 2015</xref>). Homologs of Arc3B encoded adjacent to Arc3A-like genes were identified on the basis of their classification in the Pfam 13,163.</p></sec><sec id="s4-12"><title>Bacterial stress assays</title><p><italic>P. aeruginosa</italic> cultures were assayed for the ability to survive oxidative stress (50 mM H<sub>2</sub>O<sub>2</sub>), heat stress (55°C), osmotic stress (3 M NaCl), and detergent stress (0.5% [<italic>w/v</italic>] SDS and 0.25 mM EDTA) in LB media as previously described with modifications (<xref ref-type="bibr" rid="bib23">Jørgensen et al., 1999</xref>). After incubation with the oxidative, heat, and osmotic stress conditions, cultures were serially diluted 10-fold in LB medium and plated on LB agar for subsequent analysis of remaining viable cells by CFU determination. For oxidative stress, stationary-phase cultures were diluted to OD<sub>600</sub> = 0.1 and incubated in LB media containing 50 mM H<sub>2</sub>O<sub>2</sub> for 30 min at 37°C with continuous shaking. For heat stress, stationary-phase cultures were diluted in pre-warmed LB media to OD<sub>600</sub> = 0.1 and incubated at 55°C for 30 min with continuous shaking. For osmotic stress, overnight cultures were diluted in LB media containing 3 M NaCl to OD<sub>600</sub> = 0.1. Cultures were incubated at 37°C for 20 hr with shaking. For detergent stress, cultures were serially diluted in LB media and directly plated on LB agar plates containing 0.5% (<italic>w/v</italic>) SDS and 0.25 mM EDTA for CFU quantification.</p></sec><sec id="s4-13"><title>Phospholipid analysis</title><p>To prepare [<sup>32</sup>P]-labeled bacteria, <italic>P. aeruginosa</italic> strains were grown in LB media supplemented with 5 μCi/ml [<sup>32</sup>P]-orthophosphoric acid. Tle3 intoxication was performed by mixing 200 OD<sub>600</sub> of <italic>B. thai</italic> and [<sup>32</sup>P]-<italic>P. aeruginosa</italic> at a 10:1 ratio (<italic>v/v</italic>) and incubating this mixture at 37°C for 1 hr on 3% (<italic>w/v</italic>) agar LB no-salt plates containing L-arabinose as necessary. After 1 hr of intoxication, cells were collected, and the lipids were extracted using the Bligh–Dyer method as described above. Purified lipid samples were loaded onto a silica gel thin-layer plate and developed with chloroform/methanol/acetic acid/ddH<sub>2</sub>O (85:15:10:3.5, <italic>v/v/v/v</italic>) solvent system (<xref ref-type="bibr" rid="bib34">Lopalco et al., 2017</xref>). The air-dried plate was exposed to a storage phosphor screen. Individual phospholipid was visualized and quantified using phosphorimaging to calculate phospholipid content expressed as mol% of the total phospholipid pool.</p></sec><sec id="s4-14"><title>PE regeneration assay</title><p>To generate [<sup>32</sup>P]-labeled PE, <italic>E. coli</italic> UE54 strain was grown in LB media supplemented with 5 μCi/ml [<sup>32</sup>P]-orthophosphate overnight at 37°C (<xref ref-type="bibr" rid="bib17">Harvat et al., 2005</xref>). Cells were collected and the lipids were extracted using the Bligh–Dyer method as described above. The extracted lipids were dried and resuspended in buffer containing 100 mM HEPES-NaOH, pH = 7.5, 100 mM KCl, 10 mM CaCl<sub>2</sub>, and 1% (<italic>w/v</italic>) <italic>n</italic>-Dodecyl-β-<sc>d</sc>-maltoside. 10 units of pancreas phospholipase A<sub>2</sub> were added to digest PE to LPE at 37°C overnight with shaking. After incubation, lipids were extracted and loaded onto a silica gel thin-layer plate and developed with chloroform/methanol/acetic acid/ddH<sub>2</sub>O (85:15:10:3.5, <italic>v/v/v/v</italic>) solvent system. The dried plate was exposed to an x-ray film for 2 hr. The phospholipid bands were visualized by developing the film, and bands corresponding to [<sup>32</sup>P]-LPE on the TLC plate were scraped, extracted, and resuspended in 100% ethanol.</p><p><italic>P. aeruginosa</italic> spheroplasts were generated by resuspending log-phase culture in 25 mM Tris-HCl, pH 8, 450 mM sucrose, and 1.4 mM EDTA. After addition of 20 μg/ml lysozyme, cells were incubated on ice for 30 min. Intact spheroplasts were collected by centrifugation (3000 × <italic>g</italic> for 5 min) at 4°C and gently resuspended in 25 mM Tris-HCl, pH 8, and 450 mM sucrose. To examine PE regeneration, [<sup>32</sup>P]-LPE was added into spheroplast solutions and incubated at 37°C. The reactions were terminated at the indicated time by adding chloroform-methanol mixture (1:2, <italic>v/v</italic>). The lipids were extracted, separated by TLC, and analyzed using phosphorimaging as described above (<xref ref-type="bibr" rid="bib33">Lin et al., 2019</xref>).</p></sec><sec id="s4-15"><title>Statistical analyses</title><p>GraphPad Prism 7 software (San Diego, CA) was used for statistical analysis. We used an unpaired two-tailed Student’s <italic>t</italic>-test for pairwise comparisons. In all cases, p&lt;0.05 was considered statistically significant.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Data curation</p></fn><fn fn-type="con" id="con6"><p>Data curation</p></fn><fn fn-type="con" id="con7"><p>Data curation</p></fn><fn fn-type="con" id="con8"><p>Data curation</p></fn><fn fn-type="con" id="con9"><p>Data curation</p></fn><fn fn-type="con" id="con10"><p>Data curation</p></fn><fn fn-type="con" id="con11"><p>Data curation</p></fn><fn fn-type="con" id="con12"><p>Data curation</p></fn><fn fn-type="con" id="con13"><p>Data curation</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Funding acquisition, Supervision, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-74658-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequence data associated with this study is available from the Sequence Read Archive at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/754428">BioProject PRJNA754428</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>SY</given-names></name><name><surname>Lacourse</surname><given-names>KD</given-names></name><name><surname>Ledvina</surname><given-names>HE</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Radey</surname><given-names>MC</given-names></name><name><surname>Kulasekara</surname><given-names>HD</given-names></name><name><surname>Somavanshi</surname><given-names>R</given-names></name><name><surname>Bertolli</surname><given-names>SK</given-names></name><name><surname>Gallagher</surname><given-names>LA</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Penewit</surname><given-names>KM</given-names></name><name><surname>Salipante</surname><given-names>SJ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Peterson</surname><given-names>SB</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Coordinately regulated interbacterial antagonism defense pathways constitute a bacterial innate immune system</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/754428">PRJNA754428</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Simon Dove, Josh Woodward, Lei Zheng, and Mougous laboratory members for helpful discussions, Mikhail Bogdanov and Lei Zheng for sharing reagents, and Colin Manoil and Jason Smith for sharing equipment. This work was supported by the grants from NIH (AI080609 to JDM, DK089507 to SJS, and R01AI136979 to LX) and the Cystic Fibrosis Foundation (SINGH19R0). Equipment utilized was supported by the Office of the Director, National Institutes of Health, under award number S10OD026741. JDM is an HHMI Investigator.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernheim</surname><given-names>A</given-names></name><name><surname>Sorek</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The pan-immune system of bacteria: antiviral defence as a community resource</article-title><source>Nature Reviews. Microbiology</source><volume>18</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0278-2</pub-id><pub-id pub-id-type="pmid">31695182</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bligh</surname><given-names>EG</given-names></name><name><surname>Dyer</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>A rapid method of total lipid extraction and purification</article-title><source>Canadian Journal of Biochemistry and Physiology</source><volume>37</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1139/o59-099</pub-id><pub-id pub-id-type="pmid">13671378</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>JR</given-names></name><name><surname>Duerkop</surname><given-names>BA</given-names></name><name><surname>Hinz</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>TE</given-names></name><name><surname>Herman</surname><given-names>JP</given-names></name><name><surname>Churchill</surname><given-names>MEA</given-names></name><name><surname>Skerrett</surname><given-names>SJ</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mutational analysis of Burkholderia thailandensis quorum sensing and self-aggregation</article-title><source>Journal of Bacteriology</source><volume>191</volume><fpage>5901</fpage><lpage>5909</lpage><pub-id pub-id-type="doi">10.1128/JB.00591-09</pub-id><pub-id pub-id-type="pmid">19648250</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>I-MA</given-names></name><name><surname>Chu</surname><given-names>K</given-names></name><name><surname>Palaniappan</surname><given-names>K</given-names></name><name><surname>Ratner</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Huntemann</surname><given-names>M</given-names></name><name><surname>Hajek</surname><given-names>P</given-names></name><name><surname>Ritter</surname><given-names>S</given-names></name><name><surname>Varghese</surname><given-names>N</given-names></name><name><surname>Seshadri</surname><given-names>R</given-names></name><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Woyke</surname><given-names>T</given-names></name><name><surname>Eloe-Fadrosh</surname><given-names>EA</given-names></name><name><surname>Ivanova</surname><given-names>NN</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The IMG/M data management and analysis system v.6.0: new tools and advanced capabilities</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D751</fpage><lpage>D763</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa939</pub-id><pub-id pub-id-type="pmid">33119741</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Mima</surname><given-names>T</given-names></name><name><surname>Casart</surname><given-names>Y</given-names></name><name><surname>Rholl</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Beacham</surname><given-names>IR</given-names></name><name><surname>Schweizer</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei</article-title><source>Applied and Environmental Microbiology</source><volume>74</volume><fpage>1064</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1128/AEM.02430-07</pub-id><pub-id pub-id-type="pmid">18156318</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornforth</surname><given-names>DM</given-names></name><name><surname>Foster</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Competition sensing: the social side of bacterial stress responses</article-title><source>Nature Reviews. Microbiology</source><volume>11</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2977</pub-id><pub-id pub-id-type="pmid">23456045</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>L</given-names></name><name><surname>Reményi</surname><given-names>I</given-names></name><name><surname>Tusnády</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CCTOP: a Consensus Constrained TOPology prediction web server</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W408</fpage><lpage>W412</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv451</pub-id><pub-id pub-id-type="pmid">25943549</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filkin</surname><given-names>SY</given-names></name><name><surname>Lipkin</surname><given-names>AV</given-names></name><name><surname>Fedorov</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phospholipase Superfamily: Structure, Functions, and Biotechnological Applications</article-title><source>Biochemistry. Biokhimiia</source><volume>85</volume><fpage>S177</fpage><lpage>S195</lpage><pub-id pub-id-type="doi">10.1134/S0006297920140096</pub-id><pub-id pub-id-type="pmid">32087059</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Díaz</surname><given-names>M</given-names></name><name><surname>Monturiol-Gross</surname><given-names>L</given-names></name><name><surname>Naylor</surname><given-names>C</given-names></name><name><surname>Alape-Girón</surname><given-names>A</given-names></name><name><surname>Flieger</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Bacterial Sphingomyelinases and Phospholipases as Virulence Factors</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>80</volume><fpage>597</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00082-15</pub-id><pub-id pub-id-type="pmid">27307578</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridman</surname><given-names>CM</given-names></name><name><surname>Keppel</surname><given-names>K</given-names></name><name><surname>Gerlic</surname><given-names>M</given-names></name><name><surname>Bosis</surname><given-names>E</given-names></name><name><surname>Salomon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A comparative genomics methodology reveals A widespread family of membrane-disrupting T6SS effectors</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1085</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14951-4</pub-id><pub-id pub-id-type="pmid">32109231</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methods for Tn-Seq Analysis in Acinetobacter baumannii</article-title><source>Methods in Molecular Biology</source><volume>1946</volume><fpage>115</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9118-1_12</pub-id><pub-id pub-id-type="pmid">30798550</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhardt</surname><given-names>MJ</given-names></name><name><surname>Kambara</surname><given-names>TK</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Dove</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Widespread targeting of nascent transcripts by RsmA in <italic>Pseudomonas aeruginosa</italic></article-title><source>PNAS</source><volume>117</volume><fpage>10520</fpage><lpage>10529</lpage><pub-id pub-id-type="doi">10.1073/pnas.1917587117</pub-id><pub-id pub-id-type="pmid">32332166</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>DG</given-names></name><name><surname>Young</surname><given-names>L</given-names></name><name><surname>Chuang</surname><given-names>RY</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Hutchison</surname><given-names>CA</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title><source>Nature Methods</source><volume>6</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id><pub-id pub-id-type="pmid">19363495</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>AL</given-names></name><name><surname>Kulasekara</surname><given-names>B</given-names></name><name><surname>Rietsch</surname><given-names>A</given-names></name><name><surname>Boyd</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>RS</given-names></name><name><surname>Lory</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in <italic>Pseudomonas aeruginosa</italic></article-title><source>Developmental Cell</source><volume>7</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.08.020</pub-id><pub-id pub-id-type="pmid">15525535</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granato</surname><given-names>ET</given-names></name><name><surname>Meiller-Legrand</surname><given-names>TA</given-names></name><name><surname>Foster</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Evolution and Ecology of Bacterial Warfare</article-title><source>Current Biology</source><volume>29</volume><fpage>R521</fpage><lpage>R537</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2019.04.024</pub-id><pub-id pub-id-type="pmid">31163166</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampton</surname><given-names>HG</given-names></name><name><surname>Watson</surname><given-names>BNJ</given-names></name><name><surname>Fineran</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The arms race between bacteria and their phage foes</article-title><source>Nature</source><volume>577</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1894-8</pub-id><pub-id pub-id-type="pmid">31942051</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvat</surname><given-names>EM</given-names></name><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Tran</surname><given-names>CV</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Frank</surname><given-names>MW</given-names></name><name><surname>Rock</surname><given-names>CO</given-names></name><name><surname>Saier</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Lysophospholipid flipping across the <italic>Escherichia coli</italic> inner membrane catalyzed by a transporter (LplT) belonging to the major facilitator superfamily</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>12028</fpage><lpage>12034</lpage><pub-id pub-id-type="doi">10.1074/jbc.M414368200</pub-id><pub-id pub-id-type="pmid">15661733</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>RE</given-names></name><name><surname>Gallegos-Monterrosa</surname><given-names>R</given-names></name><name><surname>Coulthurst</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Type VI secretion system effector proteins: Effective weapons for bacterial competitiveness</article-title><source>Cellular Microbiology</source><volume>22</volume><elocation-id>e13241</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.13241</pub-id><pub-id pub-id-type="pmid">32592518</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersch</surname><given-names>SJ</given-names></name><name><surname>Manera</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Defending against the Type Six Secretion System: beyond Immunity Genes</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108259</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108259</pub-id><pub-id pub-id-type="pmid">33053336</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersch</surname><given-names>SJ</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name><name><surname>Stietz</surname><given-names>MS</given-names></name><name><surname>Manera</surname><given-names>K</given-names></name><name><surname>Kamal</surname><given-names>F</given-names></name><name><surname>Burkinshaw</surname><given-names>B</given-names></name><name><surname>Lam</surname><given-names>L</given-names></name><name><surname>Pun</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Savchenko</surname><given-names>A</given-names></name><name><surname>Dong</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Envelope stress responses defend against type six secretion system attacks independently of immunity proteins</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>706</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-0672-6</pub-id><pub-id pub-id-type="pmid">32094588</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>TT</given-names></name><name><surname>Kutchma</surname><given-names>AJ</given-names></name><name><surname>Becher</surname><given-names>A</given-names></name><name><surname>Schweizer</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Integration-proficient plasmids for <italic>Pseudomonas aeruginosa</italic>: site-specific integration and use for engineering of reporter and expression strains</article-title><source>Plasmid</source><volume>43</volume><fpage>59</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1006/plas.1999.1441</pub-id><pub-id pub-id-type="pmid">10610820</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname><given-names>RD</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Hsu</surname><given-names>F</given-names></name><name><surname>Güvener</surname><given-names>T</given-names></name><name><surname>Carl</surname><given-names>MA</given-names></name><name><surname>Trinidad</surname><given-names>RRS</given-names></name><name><surname>Silverman</surname><given-names>JM</given-names></name><name><surname>Ohlson</surname><given-names>BB</given-names></name><name><surname>Hicks</surname><given-names>KG</given-names></name><name><surname>Plemel</surname><given-names>RL</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>WY</given-names></name><name><surname>Merz</surname><given-names>AJ</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A type VI secretion system of <italic>Pseudomonas aeruginosa</italic> targets A toxin to bacteria</article-title><source>Cell Host &amp; Microbe</source><volume>7</volume><fpage>25</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.12.007</pub-id><pub-id pub-id-type="pmid">20114026</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jørgensen</surname><given-names>F</given-names></name><name><surname>Bally</surname><given-names>M</given-names></name><name><surname>Chapon-Herve</surname><given-names>V</given-names></name><name><surname>Michel</surname><given-names>G</given-names></name><name><surname>Lazdunski</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>P</given-names></name><name><surname>Stewart</surname><given-names>GSAB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>RpoS-dependent stress tolerance in <italic>Pseudomonas aeruginosa</italic></article-title><source>Microbiology (Reading, England)</source><volume>145 (Pt 4)</volume><fpage>835</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1099/13500872-145-4-835</pub-id><pub-id pub-id-type="pmid">10220163</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamal</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Manera</surname><given-names>K</given-names></name><name><surname>Pei</surname><given-names>TT</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Lam</surname><given-names>LG</given-names></name><name><surname>Pun</surname><given-names>A</given-names></name><name><surname>Hersch</surname><given-names>SJ</given-names></name><name><surname>Dong</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differential Cellular Response to Translocated Toxic Effectors and Physical Penetration by the Type VI Secretion System</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107766</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107766</pub-id><pub-id pub-id-type="pmid">32553162</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulasekara</surname><given-names>HD</given-names></name><name><surname>Ventre</surname><given-names>I</given-names></name><name><surname>Kulasekara</surname><given-names>BR</given-names></name><name><surname>Lazdunski</surname><given-names>A</given-names></name><name><surname>Filloux</surname><given-names>A</given-names></name><name><surname>Lory</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A novel two-component system controls the expression of <italic>Pseudomonas aeruginosa</italic> fimbrial cup genes</article-title><source>Molecular Microbiology</source><volume>55</volume><fpage>368</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04402.x</pub-id><pub-id pub-id-type="pmid">15659157</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapouge</surname><given-names>K</given-names></name><name><surname>Schubert</surname><given-names>M</given-names></name><name><surname>Allain</surname><given-names>FH-T</given-names></name><name><surname>Haas</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour</article-title><source>Molecular Microbiology</source><volume>67</volume><fpage>241</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.06042.x</pub-id><pub-id pub-id-type="pmid">18047567</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>NH</given-names></name><name><surname>Peters</surname><given-names>K</given-names></name><name><surname>Espaillat</surname><given-names>A</given-names></name><name><surname>Sheldon</surname><given-names>JR</given-names></name><name><surname>Gray</surname><given-names>J</given-names></name><name><surname>Di Venanzio</surname><given-names>G</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name><name><surname>Djahanschiri</surname><given-names>B</given-names></name><name><surname>Mueller</surname><given-names>EA</given-names></name><name><surname>Hennon</surname><given-names>SW</given-names></name><name><surname>Levin</surname><given-names>PA</given-names></name><name><surname>Ebersberger</surname><given-names>I</given-names></name><name><surname>Skaar</surname><given-names>EP</given-names></name><name><surname>Cava</surname><given-names>F</given-names></name><name><surname>Vollmer</surname><given-names>W</given-names></name><name><surname>Feldman</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Peptidoglycan editing provides immunity to <italic>Acinetobacter baumannii</italic> during bacterial warfare</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabb5614</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb5614</pub-id><pub-id pub-id-type="pmid">32832672</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Go</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>IH</given-names></name><name><surname>Shin</surname><given-names>JS</given-names></name><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Yoon</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A Genetic Screen Reveals Novel Targets to Render <italic>Pseudomonas aeruginosa</italic> Sensitive to Lysozyme and Cell Wall-Targeting Antibiotics</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>7</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00059</pub-id><pub-id pub-id-type="pmid">28299285</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeRoux</surname><given-names>M</given-names></name><name><surname>De Leon</surname><given-names>JA</given-names></name><name><surname>Kuwada</surname><given-names>NJ</given-names></name><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>Pinto-Santini</surname><given-names>D</given-names></name><name><surname>Hood</surname><given-names>RD</given-names></name><name><surname>Agnello</surname><given-names>DM</given-names></name><name><surname>Robertson</surname><given-names>SM</given-names></name><name><surname>Wiggins</surname><given-names>PA</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Quantitative single-cell characterization of bacterial interactions reveals type VI secretion is a double-edged sword</article-title><source>PNAS</source><volume>109</volume><fpage>19804</fpage><lpage>19809</lpage><pub-id pub-id-type="doi">10.1073/pnas.1213963109</pub-id><pub-id pub-id-type="pmid">23150540</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeRoux</surname><given-names>M</given-names></name><name><surname>Kirkpatrick</surname><given-names>RL</given-names></name><name><surname>Montauti</surname><given-names>EI</given-names></name><name><surname>Tran</surname><given-names>BQ</given-names></name><name><surname>Peterson</surname><given-names>SB</given-names></name><name><surname>Harding</surname><given-names>BN</given-names></name><name><surname>Whitney</surname><given-names>JC</given-names></name><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>Traxler</surname><given-names>B</given-names></name><name><surname>Goo</surname><given-names>YA</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>Wiggins</surname><given-names>PA</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Kin cell lysis is a danger signal that activates antibacterial pathways of <italic>Pseudomonas aeruginosa</italic></article-title><source>eLife</source><volume>4</volume><elocation-id>e05701</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05701</pub-id><pub-id pub-id-type="pmid">25643398</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeRoux</surname><given-names>M</given-names></name><name><surname>Peterson</surname><given-names>SB</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Bacterial danger sensing</article-title><source>Journal of Molecular Biology</source><volume>427</volume><fpage>3744</fpage><lpage>3753</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2015.09.018</pub-id><pub-id pub-id-type="pmid">26434507</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Bogdanov</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Margolin</surname><given-names>W</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>3386</fpage><lpage>3398</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.001231</pub-id><pub-id pub-id-type="pmid">29348168</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Bogdanov</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Measurement of Lysophospholipid Transport Across the Membrane Using <italic>Escherichia coli</italic> Spheroplasts</article-title><source>Methods in Molecular Biology</source><volume>1949</volume><fpage>165</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9136-5_13</pub-id><pub-id pub-id-type="pmid">30790256</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopalco</surname><given-names>P</given-names></name><name><surname>Stahl</surname><given-names>J</given-names></name><name><surname>Annese</surname><given-names>C</given-names></name><name><surname>Averhoff</surname><given-names>B</given-names></name><name><surname>Corcelli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>2972</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-03214-w</pub-id><pub-id pub-id-type="pmid">28592862</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lories</surname><given-names>B</given-names></name><name><surname>Roberfroid</surname><given-names>S</given-names></name><name><surname>Dieltjens</surname><given-names>L</given-names></name><name><surname>De Coster</surname><given-names>D</given-names></name><name><surname>Foster</surname><given-names>KR</given-names></name><name><surname>Steenackers</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Biofilm Bacteria Use Stress Responses to Detect and Respond to Competitors</article-title><source>Current Biology</source><volume>30</volume><fpage>1231</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.01.065</pub-id><pub-id pub-id-type="pmid">32084407</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Matsen Group</collab></person-group><year iso-8601-date="2020">2020</year><data-title>seqmagick</data-title><version designator="0.8.0">0.8.0</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/fhcrc/seqmagick">https://github.com/fhcrc/seqmagick</ext-link></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morehouse</surname><given-names>BR</given-names></name><name><surname>Govande</surname><given-names>AA</given-names></name><name><surname>Millman</surname><given-names>A</given-names></name><name><surname>Keszei</surname><given-names>AFA</given-names></name><name><surname>Lowey</surname><given-names>B</given-names></name><name><surname>Ofir</surname><given-names>G</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name><name><surname>Sorek</surname><given-names>R</given-names></name><name><surname>Kranzusch</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>STING cyclic dinucleotide sensing originated in bacteria</article-title><source>Nature</source><volume>586</volume><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2719-5</pub-id><pub-id pub-id-type="pmid">32877915</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mougous</surname><given-names>JD</given-names></name><name><surname>Cuff</surname><given-names>ME</given-names></name><name><surname>Raunser</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Gifford</surname><given-names>CA</given-names></name><name><surname>Goodman</surname><given-names>AL</given-names></name><name><surname>Joachimiak</surname><given-names>G</given-names></name><name><surname>Ordoñez</surname><given-names>CL</given-names></name><name><surname>Lory</surname><given-names>S</given-names></name><name><surname>Walz</surname><given-names>T</given-names></name><name><surname>Joachimiak</surname><given-names>A</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A virulence locus of <italic>Pseudomonas aeruginosa</italic> encodes A protein secretion apparatus</article-title><source>Science (New York, N.Y.)</source><volume>312</volume><fpage>1526</fpage><lpage>1530</lpage><pub-id pub-id-type="doi">10.1126/science.1128393</pub-id><pub-id pub-id-type="pmid">16763151</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munguia</surname><given-names>J</given-names></name><name><surname>LaRock</surname><given-names>DL</given-names></name><name><surname>Tsunemoto</surname><given-names>H</given-names></name><name><surname>Olson</surname><given-names>J</given-names></name><name><surname>Cornax</surname><given-names>I</given-names></name><name><surname>Pogliano</surname><given-names>J</given-names></name><name><surname>Nizet</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Mla pathway is critical for <italic>Pseudomonas aeruginosa</italic> resistance to outer membrane permeabilization and host innate immune clearance</article-title><source>Journal of Molecular Medicine (Berlin, Germany)</source><volume>95</volume><fpage>1127</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1007/s00109-017-1579-4</pub-id><pub-id pub-id-type="pmid">28844103</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Pradeu</surname><given-names>T</given-names></name><name><surname>Masters</surname><given-names>SL</given-names></name><name><surname>Mogensen</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Constitutive immune mechanisms: mediators of host defence and immune regulation</article-title><source>Nature Reviews. Immunology</source><volume>21</volume><fpage>137</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0391-5</pub-id><pub-id pub-id-type="pmid">32782357</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Press</surname><given-names>CM</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Kobayashi</surname><given-names>DY</given-names></name><name><surname>Myers</surname><given-names>GSA</given-names></name><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>DeBoy</surname><given-names>RT</given-names></name><name><surname>Seshadri</surname><given-names>R</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Madupu</surname><given-names>R</given-names></name><name><surname>Dodson</surname><given-names>RJ</given-names></name><name><surname>Durkin</surname><given-names>AS</given-names></name><name><surname>Brinkac</surname><given-names>LM</given-names></name><name><surname>Daugherty</surname><given-names>SC</given-names></name><name><surname>Sullivan</surname><given-names>SA</given-names></name><name><surname>Rosovitz</surname><given-names>MJ</given-names></name><name><surname>Gwinn</surname><given-names>ML</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Schneider</surname><given-names>DJ</given-names></name><name><surname>Cartinhour</surname><given-names>SW</given-names></name><name><surname>Nelson</surname><given-names>WC</given-names></name><name><surname>Weidman</surname><given-names>J</given-names></name><name><surname>Watkins</surname><given-names>K</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Khouri</surname><given-names>H</given-names></name><name><surname>Pierson</surname><given-names>EA</given-names></name><name><surname>Pierson</surname><given-names>LS</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name><name><surname>Loper</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5</article-title><source>Nature Biotechnology</source><volume>23</volume><fpage>873</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1038/nbt1110</pub-id><pub-id pub-id-type="pmid">15980861</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>SB</given-names></name><name><surname>Bertolli</surname><given-names>SK</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Central Role of Interbacterial Antagonism in Bacterial Life</article-title><source>Current Biology</source><volume>30</volume><fpage>R1203</fpage><lpage>R1214</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.06.103</pub-id><pub-id pub-id-type="pmid">33022265</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietsch</surname><given-names>A</given-names></name><name><surname>Vallet-Gely</surname><given-names>I</given-names></name><name><surname>Dove</surname><given-names>SL</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>ExsE, a secreted regulator of type III secretion genes in <italic>Pseudomonas aeruginosa</italic></article-title><source>PNAS</source><volume>102</volume><fpage>8006</fpage><lpage>8011</lpage><pub-id pub-id-type="doi">10.1073/pnas.0503005102</pub-id><pub-id pub-id-type="pmid">15911752</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robitaille</surname><given-names>S</given-names></name><name><surname>Trus</surname><given-names>E</given-names></name><name><surname>Ross</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Bacterial Defense against the Type VI Secretion System</article-title><source>Trends in Microbiology</source><volume>29</volume><fpage>187</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2020.09.001</pub-id><pub-id pub-id-type="pmid">32951987</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>BD</given-names></name><name><surname>Verster</surname><given-names>AJ</given-names></name><name><surname>Radey</surname><given-names>MC</given-names></name><name><surname>Schmidtke</surname><given-names>DT</given-names></name><name><surname>Pope</surname><given-names>CE</given-names></name><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>Hajjar</surname><given-names>AM</given-names></name><name><surname>Peterson</surname><given-names>SB</given-names></name><name><surname>Borenstein</surname><given-names>E</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human gut bacteria contain acquired interbacterial defence systems</article-title><source>Nature</source><volume>575</volume><fpage>224</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1708-z</pub-id><pub-id pub-id-type="pmid">31666699</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Brittnacher</surname><given-names>M</given-names></name><name><surname>Bui</surname><given-names>NK</given-names></name><name><surname>Hood</surname><given-names>RD</given-names></name><name><surname>Carl</surname><given-names>MA</given-names></name><name><surname>Agnello</surname><given-names>DM</given-names></name><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>Vollmer</surname><given-names>W</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A Widespread Bacterial Type VI Secretion Effector Superfamily Identified Using A Heuristic Approach</article-title><source>Cell Host &amp; Microbe</source><volume>11</volume><fpage>538</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.04.007</pub-id><pub-id pub-id-type="pmid">22607806</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>LeRoux</surname><given-names>M</given-names></name><name><surname>Hathazi</surname><given-names>K</given-names></name><name><surname>Agnello</surname><given-names>DM</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Wiggins</surname><given-names>PA</given-names></name><name><surname>Wai</surname><given-names>SN</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors</article-title><source>Nature</source><volume>496</volume><fpage>508</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/nature12074</pub-id><pub-id pub-id-type="pmid">23552891</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomon</surname><given-names>D</given-names></name><name><surname>Kinch</surname><given-names>LN</given-names></name><name><surname>Trudgian</surname><given-names>DC</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Klimko</surname><given-names>JA</given-names></name><name><surname>Grishin</surname><given-names>NV</given-names></name><name><surname>Mirzaei</surname><given-names>H</given-names></name><name><surname>Orth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Marker for type VI secretion system effectors</article-title><source>PNAS</source><volume>111</volume><fpage>9271</fpage><lpage>9276</lpage><pub-id pub-id-type="doi">10.1073/pnas.1406110111</pub-id><pub-id pub-id-type="pmid">24927539</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>West</surname><given-names>TE</given-names></name><name><surname>Boyer</surname><given-names>F</given-names></name><name><surname>Chiang</surname><given-names>WC</given-names></name><name><surname>Carl</surname><given-names>MA</given-names></name><name><surname>Hood</surname><given-names>RD</given-names></name><name><surname>Rohmer</surname><given-names>L</given-names></name><name><surname>Tolker-Nielsen</surname><given-names>T</given-names></name><name><surname>Skerrett</surname><given-names>SJ</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name><name><surname>Christie</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Burkholderia Type VI Secretion Systems Have Distinct Roles in Eukaryotic and Bacterial Cell Interactions</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1001068</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1001068</pub-id><pub-id pub-id-type="pmid">20865170</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiva</surname><given-names>S</given-names></name><name><surname>Vu</surname><given-names>HS</given-names></name><name><surname>Roth</surname><given-names>MR</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Marepally</surname><given-names>SR</given-names></name><name><surname>Nune</surname><given-names>DS</given-names></name><name><surname>Lushington</surname><given-names>GH</given-names></name><name><surname>Visvanathan</surname><given-names>M</given-names></name><name><surname>Welti</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lipidomic analysis of plant membrane lipids by direct infusion tandem mass spectrometry</article-title><source>Methods in Molecular Biology</source><volume>1009</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-401-2_9</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>JM</given-names></name><name><surname>Austin</surname><given-names>LS</given-names></name><name><surname>Hsu</surname><given-names>F</given-names></name><name><surname>Hicks</surname><given-names>KG</given-names></name><name><surname>Hood</surname><given-names>RD</given-names></name><name><surname>Mougous</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Separate inputs modulate phosphorylation-dependent and -independent type VI secretion activation</article-title><source>Molecular Microbiology</source><volume>82</volume><fpage>1277</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07889.x</pub-id><pub-id pub-id-type="pmid">22017253</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>J</given-names></name><name><surname>Houry</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>MoxR AAA+ ATPases: a novel family of molecular chaperones?</article-title><source>Journal of Structural Biology</source><volume>156</volume><fpage>200</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2006.02.009</pub-id><pub-id pub-id-type="pmid">16677824</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stover</surname><given-names>CK</given-names></name><name><surname>Pham</surname><given-names>XQ</given-names></name><name><surname>Erwin</surname><given-names>AL</given-names></name><name><surname>Mizoguchi</surname><given-names>SD</given-names></name><name><surname>Warrener</surname><given-names>P</given-names></name><name><surname>Hickey</surname><given-names>MJ</given-names></name><name><surname>Brinkman</surname><given-names>FS</given-names></name><name><surname>Hufnagle</surname><given-names>WO</given-names></name><name><surname>Kowalik</surname><given-names>DJ</given-names></name><name><surname>Lagrou</surname><given-names>M</given-names></name><name><surname>Garber</surname><given-names>RL</given-names></name><name><surname>Goltry</surname><given-names>L</given-names></name><name><surname>Tolentino</surname><given-names>E</given-names></name><name><surname>Westbrock-Wadman</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Brody</surname><given-names>LL</given-names></name><name><surname>Coulter</surname><given-names>SN</given-names></name><name><surname>Folger</surname><given-names>KR</given-names></name><name><surname>Kas</surname><given-names>A</given-names></name><name><surname>Larbig</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Spencer</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>GK</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Reizer</surname><given-names>J</given-names></name><name><surname>Saier</surname><given-names>MH</given-names></name><name><surname>Hancock</surname><given-names>RE</given-names></name><name><surname>Lory</surname><given-names>S</given-names></name><name><surname>Olson</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Complete genome sequence of <italic>Pseudomonas aeruginosa</italic> PAO1, an opportunistic pathogen</article-title><source>Nature</source><volume>406</volume><fpage>959</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1038/35023079</pub-id><pub-id pub-id-type="pmid">10984043</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toska</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>BT</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Exopolysaccharide protects <italic>Vibrio cholerae</italic> from exogenous attacks by the type 6 secretion system</article-title><source>PNAS</source><volume>115</volume><fpage>7997</fpage><lpage>8002</lpage><pub-id pub-id-type="doi">10.1073/pnas.1808469115</pub-id><pub-id pub-id-type="pmid">30021850</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>YCC</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Liew</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Bhushan</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>YG</given-names></name><name><surname>Mueller-Cajar</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Insights into the mechanism and regulation of the CbbQO-type Rubisco activase, a MoxR AAA+ ATPase</article-title><source>PNAS</source><volume>117</volume><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1073/pnas.1911123117</pub-id><pub-id pub-id-type="pmid">31848241</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>S</given-names></name><name><surname>Tommassen</surname><given-names>J</given-names></name><name><surname>Jaeger</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A novel lipolytic enzyme located in the outer membrane of <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>6977</fpage><lpage>6986</lpage><pub-id pub-id-type="doi">10.1128/JB.181.22.6977-6986.1999</pub-id><pub-id pub-id-type="pmid">10559163</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Chua</surname><given-names>HH</given-names></name><name><surname>Lin</surname><given-names>CH</given-names></name><name><surname>Sim</surname><given-names>SH</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Derr</surname><given-names>A</given-names></name><name><surname>Engels</surname><given-names>R</given-names></name><name><surname>DeShazer</surname><given-names>D</given-names></name><name><surname>Birren</surname><given-names>B</given-names></name><name><surname>Nierman</surname><given-names>WC</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis</article-title><source>BMC Microbiology</source><volume>6</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-6-46</pub-id><pub-id pub-id-type="pmid">16725056</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Bogdanov</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biogenesis, transport and remodeling of lysophospholipids in Gram-negative bacteria</article-title><source>Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids</source><volume>1862</volume><fpage>1404</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2016.11.015</pub-id><pub-id pub-id-type="pmid">27956138</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Mass spectrometric analysis of <italic>P. aeruginosa</italic> Arc3A and Arc3B immunoprecipitation samples.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Locus ID<sup><xref ref-type="table-fn" rid="app1table1fn1">*</xref></sup></th><th align="left" valign="bottom">Peptide counts of sample (%)<sup><xref ref-type="table-fn" rid="app1table1fn2">†</xref></sup></th><th align="left" valign="bottom">Fold change (VSV-G/Ctrl <xref ref-type="table-fn" rid="app1table1fn3"><sup>‡</sup></xref>)</th></tr></thead><tbody><tr><td align="left" colspan="3" valign="bottom">Arc3B-VSV-G sample</td></tr><tr><td align="left" valign="bottom"><bold>PA5113 (Arc3B</bold>)</td><td align="char" char="." valign="bottom"><bold>5.86</bold></td><td align="left" valign="bottom"><bold>&gt; 200</bold></td></tr><tr><td align="left" valign="bottom">PA4385</td><td align="char" char="." valign="bottom">1.62</td><td align="left" valign="bottom">2.29</td></tr><tr><td align="left" valign="bottom">PA5016</td><td align="char" char="." valign="bottom">1.45</td><td align="left" valign="bottom">0.82</td></tr><tr><td align="left" valign="bottom">PA0090</td><td align="char" char="." valign="bottom">1.17</td><td align="left" valign="bottom">0.72</td></tr><tr><td align="left" valign="bottom">PA3729</td><td align="char" char="." valign="bottom">1.12</td><td align="left" valign="bottom">1.30</td></tr><tr><td align="left" valign="bottom">PA4761</td><td align="char" char="." valign="bottom">1.12</td><td align="left" valign="bottom">0.71</td></tr><tr><td align="left" valign="bottom"><bold>PA5114 (Arc3A</bold>)</td><td align="char" char="." valign="bottom"><bold>1.12</bold></td><td align="left" valign="bottom"><bold>N.D</bold>. <sup><xref ref-type="table-fn" rid="app1table1fn4">§</xref></sup></td></tr><tr><td align="left" valign="bottom">PA5239</td><td align="char" char="." valign="bottom">1.06</td><td align="left" valign="bottom">1.10</td></tr><tr><td align="left" valign="bottom">PA3861</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">1.10</td></tr><tr><td align="left" valign="bottom">PA4269</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">1.10</td></tr><tr><td align="left" valign="bottom">PA1092</td><td align="char" char="." valign="bottom">0.95</td><td align="left" valign="bottom">0.78</td></tr><tr><td align="left" valign="bottom">PA0141</td><td align="char" char="." valign="bottom">0.89</td><td align="left" valign="bottom">0.71</td></tr><tr><td align="left" valign="bottom">PA0963</td><td align="char" char="." valign="bottom">0.84</td><td align="left" valign="bottom">1.27</td></tr><tr><td align="left" valign="bottom">PA2976</td><td align="char" char="." valign="bottom">0.84</td><td align="left" valign="bottom">0.83</td></tr><tr><td align="left" valign="bottom">PA4260</td><td align="char" char="." valign="bottom">0.84</td><td align="left" valign="bottom">0.69</td></tr><tr><td align="left" valign="bottom">PA4265</td><td align="char" char="." valign="bottom">0.84</td><td align="left" valign="bottom">0.61</td></tr><tr><td align="left" valign="bottom">PA4270</td><td align="char" char="." valign="bottom">0.84</td><td align="left" valign="bottom">1.04</td></tr><tr><td align="left" valign="bottom">PA1803</td><td align="char" char="." valign="bottom">0.78</td><td align="left" valign="bottom">0.74</td></tr><tr><td align="left" valign="bottom">PA2151</td><td align="char" char="." valign="bottom">0.78</td><td align="left" valign="bottom">0.77</td></tr><tr><td align="left" valign="bottom">PA3950</td><td align="char" char="." valign="bottom">0.78</td><td align="left" valign="bottom">1.19</td></tr><tr><td align="left" valign="bottom">PA3001</td><td align="char" char="." valign="bottom">0.73</td><td align="left" valign="bottom">1.10</td></tr><tr><td align="left" valign="bottom">PA3656</td><td align="char" char="." valign="bottom">0.73</td><td align="left" valign="bottom">0.80</td></tr><tr><td align="left" valign="bottom">PA5173</td><td align="char" char="." valign="bottom">0.73</td><td align="left" valign="bottom">0.76</td></tr><tr><td align="left" valign="bottom">PA5554</td><td align="char" char="." valign="bottom">0.73</td><td align="left" valign="bottom">1.20</td></tr><tr><td align="left" valign="bottom">PA5556</td><td align="char" char="." valign="bottom">0.73</td><td align="left" valign="bottom">2.05</td></tr><tr><td align="left" valign="bottom">Arc3A-VSV-G sample</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">PA5554</td><td align="char" char="." valign="bottom">2.92</td><td align="left" valign="bottom">4.81</td></tr><tr><td align="left" valign="bottom"><bold>PA5113 (Arc3B</bold>)</td><td align="char" char="." valign="bottom"><bold>2.22</bold></td><td align="left" valign="bottom"><bold>&gt; 200</bold></td></tr><tr><td align="left" valign="bottom"><bold>PA5114 (Arc3A</bold>)</td><td align="char" char="." valign="bottom"><bold>1.44</bold></td><td align="left" valign="bottom"><bold>N.D</bold>.</td></tr><tr><td align="left" valign="bottom">PA4751</td><td align="char" char="." valign="bottom">1.30</td><td align="left" valign="bottom">12.87</td></tr><tr><td align="left" valign="bottom">PA5556</td><td align="char" char="." valign="bottom">1.26</td><td align="left" valign="bottom">3.55</td></tr><tr><td align="left" valign="bottom">PA3729</td><td align="char" char="." valign="bottom">1.10</td><td align="left" valign="bottom">1.28</td></tr><tr><td align="left" valign="bottom">PA5016</td><td align="char" char="." valign="bottom">1.10</td><td align="left" valign="bottom">0.62</td></tr><tr><td align="left" valign="bottom">PA4429</td><td align="char" char="." valign="bottom">0.99</td><td align="left" valign="bottom">N.D.</td></tr><tr><td align="left" valign="bottom">PA4942</td><td align="char" char="." valign="bottom">0.96</td><td align="left" valign="bottom">6.36</td></tr><tr><td align="left" valign="bottom">PA2493</td><td align="char" char="." valign="bottom">0.92</td><td align="left" valign="bottom">2.60</td></tr><tr><td align="left" valign="bottom">PA3160</td><td align="char" char="." valign="bottom">0.90</td><td align="left" valign="bottom">N.D.</td></tr><tr><td align="left" valign="bottom">PA4246</td><td align="char" char="." valign="bottom">0.87</td><td align="left" valign="bottom">0.79</td></tr><tr><td align="left" valign="bottom">PA0090</td><td align="char" char="." valign="bottom">0.85</td><td align="left" valign="bottom">0.53</td></tr><tr><td align="left" valign="bottom">PA1552</td><td align="char" char="." valign="bottom">0.83</td><td align="left" valign="bottom">N.D.</td></tr><tr><td align="left" valign="bottom">PA0077</td><td align="char" char="." valign="bottom">0.81</td><td align="left" valign="bottom">5.33</td></tr><tr><td align="left" valign="bottom">PA2494</td><td align="char" char="." valign="bottom">0.81</td><td align="left" valign="bottom">ND</td></tr><tr><td align="left" valign="bottom">PA2976</td><td align="char" char="." valign="bottom">0.72</td><td align="left" valign="bottom">0.71</td></tr><tr><td align="left" valign="bottom">PA0659</td><td align="char" char="." valign="bottom">0.70</td><td align="left" valign="bottom">N.D.</td></tr><tr><td align="left" valign="bottom">PA4761</td><td align="char" char="." valign="bottom">0.70</td><td align="left" valign="bottom">0.44</td></tr><tr><td align="left" valign="bottom">PA4941</td><td align="char" char="." valign="bottom">0.65</td><td align="left" valign="bottom">2.57</td></tr><tr><td align="left" valign="bottom">PA4265</td><td align="char" char="." valign="bottom">0.63</td><td align="left" valign="bottom">0.46</td></tr><tr><td align="left" valign="bottom">PA3656</td><td align="char" char="." valign="bottom">0.61</td><td align="left" valign="bottom">0.67</td></tr><tr><td align="left" valign="bottom">PA3794</td><td align="char" char="." valign="bottom">0.61</td><td align="left" valign="bottom">N.D.</td></tr><tr><td align="left" valign="bottom">PA2151</td><td align="char" char="." valign="bottom">0.56</td><td align="left" valign="bottom">0.55</td></tr><tr><td align="left" valign="bottom">PA3821</td><td align="char" char="." valign="bottom">0.56</td><td align="left" valign="bottom">N.D.</td></tr></tbody></table><table-wrap-foot><fn id="app1table1fn1"><label>*</label><p> Proteins containing at least two peptides identified in a given immunoprecipitation sample are included. Arc3A and Arc3B are bolded.</p></fn><fn id="app1table1fn2"><label>†</label><p> Value corresponds to the abundance (peptide counts) of the protein within the total immunoprecipitation sample. Only the 25 most abundant proteins in each sample are shown.</p></fn><fn id="app1table1fn3"><label>‡</label><p> Immunoprecipitation from a <italic>P. aeruginosa</italic> strain lacking a VSV-G-tagged protein served as the control sample (Ctrl).</p></fn><fn id="app1table1fn4"><label>§</label><p> The protein was not detected in the control sample.</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Internal standards and parameters used in lipidomic analysis.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="3" valign="bottom">Internal standards used</th></tr><tr><th align="center" valign="bottom">Compound formula</th><th align="center" valign="bottom">Compound Name</th><th align="center" valign="top">Alternative name</th></tr></thead><tbody><tr><td align="left" valign="bottom">C20H41O9P</td><td align="left" valign="bottom">LysoPG(14:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C24H49O9P</td><td align="left" valign="bottom">LysoPG(18:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C34H67O10P</td><td align="left" valign="bottom">PG(14:0/14:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C46H91O10P</td><td align="left" colspan="2" valign="bottom">PG(20:0/20:0), i.e. diphytanoyl PG</td></tr><tr><td align="left" valign="bottom">C19H40O7PN</td><td align="left" valign="bottom">LysoPE(14:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C23H48O7PN</td><td align="left" valign="bottom">LysoPE(18:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C29H58O8PN</td><td align="left" valign="bottom">PE(12:0/12:0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C45H90O8PN</td><td align="left" valign="bottom">PE(20:0/20:0), i.e. diphytanoyl PE</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">C66H120O17P2</td><td align="left" valign="bottom">CL(57:4)</td><td align="left" valign="bottom">14:1(3)–15:1 CA</td></tr><tr><td align="left" valign="bottom">C70H134O17P2</td><td align="left" valign="bottom">CL(61:1)</td><td align="left" valign="bottom">15:0(3)–16:1 CA</td></tr><tr><td align="left" valign="bottom">C89H166O17P2</td><td align="left" valign="bottom">CL(80:4)</td><td align="left" valign="bottom">22:1(3)–14:1 CA</td></tr><tr><th align="center" colspan="2" valign="top">Mass spectrometry global parameters on Waters Xevo TQS mass spectrometer</th></tr><tr><td align="left" valign="bottom">Parameter</td><td align="left" valign="bottom">Value</td></tr><tr><td align="left" valign="bottom">Cycle time</td><td align="left" valign="bottom">Automatic</td></tr><tr><td align="left" valign="bottom">Source temperature (°C)</td><td align="left" valign="bottom">150</td></tr><tr><td align="left" valign="bottom">Desolvation temperature (°C)</td><td align="left" valign="bottom">250</td></tr><tr><td align="left" valign="bottom">Cone gas flow (L/h)</td><td align="left" valign="bottom">150</td></tr><tr><td align="left" valign="bottom">Desolvation gas fow (L/h)</td><td align="left" valign="bottom">650</td></tr><tr><td align="left" valign="bottom">Collision gas flow (mL/min)</td><td align="left" valign="bottom">0.14</td></tr><tr><td align="left" valign="bottom">Nebuliser gas (Bar)</td><td align="left" valign="bottom">7</td></tr><tr><td align="left" valign="bottom">LM 1 Resolution</td><td align="left" valign="bottom">2.8</td></tr><tr><td align="left" valign="bottom">HM 1 Resolution</td><td align="left" valign="bottom">14.8</td></tr><tr><th align="center" colspan="9" valign="bottom">Mass spectral acquisition and data processing parameters</th></tr><tr><th align="center" colspan="9" valign="bottom">Acquisition parameters</th></tr><tr><th align="center" valign="bottom">Compound</th><th align="center" valign="bottom">Function</th><th align="center" valign="bottom">m/z range</th><th align="center" valign="bottom">Start/end time (min)</th><th align="center" valign="bottom">Scan duration (s)</th><th align="center" valign="bottom">Ionization mode</th><th align="center" valign="bottom">Cone voltage (V)</th><th align="center" valign="bottom">Collision energy (V)</th><th align="center" valign="bottom">Total scan time (min)</th></tr><tr><td align="char" char="." valign="bottom">PG</td><td align="char" char="." valign="bottom">Neutral Loss of 189.04</td><td align="char" char="." valign="bottom">680–880</td><td align="left" valign="bottom">1.6–5</td><td align="left" valign="bottom">2</td><td align="left" valign="bottom">ES+</td><td align="left" valign="bottom">30</td><td align="left" valign="bottom">8</td><td align="left" valign="bottom">3.4</td></tr><tr><td align="char" char="." valign="bottom">LPE, PE</td><td align="char" char="." valign="bottom">Neutral Loss of 141.02</td><td align="char" char="." valign="bottom">422–922</td><td align="left" valign="bottom">1.6–5</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">ES+</td><td align="left" valign="bottom">40</td><td align="left" valign="bottom">20</td><td align="left" valign="bottom">3.4</td></tr><tr><td align="char" char="." valign="bottom">LPG</td><td align="char" char="." valign="bottom">Parents of 152.9</td><td align="char" char="." valign="bottom">420–570</td><td align="left" valign="bottom">5.2–10</td><td align="left" valign="bottom">0.75</td><td align="left" valign="bottom">ES-</td><td align="left" valign="bottom">30</td><td align="left" valign="bottom">38</td><td align="left" valign="bottom">4.8</td></tr><tr><td align="char" char="." valign="bottom">CL, MLCL</td><td align="char" char="." valign="bottom">Parents of 153</td><td align="char" char="." valign="bottom">865–1,572</td><td align="left" valign="bottom">1.6–30</td><td align="left" valign="bottom">4.7</td><td align="left" valign="bottom">ES-</td><td align="left" valign="bottom">40</td><td align="left" valign="bottom">75</td><td align="left" valign="bottom">28.4</td></tr><tr><th align="center" colspan="3" valign="bottom">Data processing parameters</th></tr><tr><th align="center" valign="bottom">Subtraction</th><th align="center" valign="bottom">Smooth mean</th><th align="center" valign="bottom">Centroid mid peak width at half height (all top 50%)</th></tr><tr><td align="char" char="." valign="bottom">1, 40, 0.01</td><td align="char" char="." valign="bottom">2 × 0.4</td><td align="char" char="." valign="bottom">2</td></tr><tr><td align="char" char="." valign="bottom">1, 40, 0.01</td><td align="char" char="." valign="bottom">2 × 0.4</td><td align="char" char="." valign="bottom">2</td></tr><tr><td align="char" char="." valign="bottom">1, 40, 0.01</td><td align="char" char="." valign="bottom">1 × 0.6</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="char" char="." valign="bottom">1, 40, 0.01</td><td align="char" char="." valign="bottom">2 × 0.6</td><td align="char" char="." valign="bottom">5</td></tr></tbody></table></table-wrap><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Transposon sequencing data summary.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Growth experiment</th><th align="left" valign="top">Mutant pool pre-competition</th><th align="left" valign="top">Pool with WT <italic>B. thai</italic> - rep 1</th><th align="left" valign="top">Pool with δt6s <italic>B. thai</italic> - rep 1</th></tr></thead><tbody><tr><td align="left" valign="top">fastq file name</td><td align="left" valign="top">tn_mutant_pool.fastq</td><td align="left" valign="top">pool_v_wt_rep1.fastq</td><td align="left" valign="top">pool_v_deltaT6_rep1.fastq</td></tr><tr><td align="left" valign="top">Total reads</td><td align="left" valign="top">515,434</td><td align="left" valign="top">5,788,728</td><td align="left" valign="top">6,452,899</td></tr><tr><td align="left" valign="top">Trimmed (valid Tn prefix)</td><td align="left" valign="top">515,293</td><td align="left" valign="top">5,786,427</td><td align="left" valign="top">6,450,594</td></tr><tr><td align="left" valign="top">Mapped</td><td align="left" valign="top">350,923</td><td align="left" valign="top">4,666,597</td><td align="left" valign="top">5,283,645</td></tr><tr><td align="left" valign="top">Mapped to TA sites</td><td align="left" valign="top">349,915</td><td align="left" valign="top">4,634,942</td><td align="left" valign="top">5,241,672</td></tr><tr><td align="left" valign="top">TA_sites</td><td align="left" valign="top">94,404</td><td align="left" valign="top">94,404</td><td align="left" valign="top">94,404</td></tr><tr><td align="left" valign="top">TAs_hit</td><td align="left" valign="top">50,348</td><td align="left" valign="top">57,644</td><td align="left" valign="top">60,331</td></tr><tr><td align="left" valign="top">Max reads per TA site</td><td align="left" valign="top">324</td><td align="left" valign="top">9,519</td><td align="left" valign="top">5,886</td></tr><tr><td align="left" valign="top">Mean reads per hit TA site</td><td align="left" valign="top">6.9</td><td align="left" valign="top">80.4</td><td align="left" valign="top">86.9</td></tr><tr><td align="left" valign="top"><bold>Pool with WT</bold> <italic><bold>B.thai</bold></italic> <bold>- rep 2</bold></td><td align="left" valign="top"><bold>Pool with ΔT6S</bold> <italic><bold>B.thai</bold></italic> <bold>- rep 2</bold></td><td align="left" valign="top"><bold>Pool with</bold> <italic><bold>tle3</bold></italic><sup><bold>S264A</bold></sup> <italic><bold>B. thai</bold></italic></td><td align="left" valign="top"><bold>Pool with Δ</bold><italic><bold>colA B. thai</bold></italic></td></tr><tr><td align="left" valign="top">pool_v_wt_rep2.fastq</td><td align="left" valign="top">pool_v_deltaT6_rep2.fastq</td><td align="left" valign="top">pool_v_tle3.fastq</td><td align="left" valign="top">pool_v_colA.fastq</td></tr><tr><td align="left" valign="top">411,515</td><td align="left" valign="top">720,133</td><td align="left" valign="top">3,226,978</td><td align="left" valign="top">3,130,545</td></tr><tr><td align="left" valign="top">411,401</td><td align="left" valign="top">719,895</td><td align="left" valign="top">3,225,816</td><td align="left" valign="top">3,129,574</td></tr><tr><td align="left" valign="top">266,466</td><td align="left" valign="top">481,466</td><td align="left" valign="top">3,024,047</td><td align="left" valign="top">2,938,318</td></tr><tr><td align="left" valign="top">265,661</td><td align="left" valign="top">479,769</td><td align="left" valign="top">2,997,466</td><td align="left" valign="top">2,922,995</td></tr><tr><td align="left" valign="top">94,404</td><td align="left" valign="top">94,404</td><td align="left" valign="top">94,404</td><td align="left" valign="top">94,404</td></tr><tr><td align="left" valign="top">46,500</td><td align="left" valign="top">53,148</td><td align="left" valign="top">59,145</td><td align="left" valign="top">58,101</td></tr><tr><td align="left" valign="top">669</td><td align="left" valign="top">447</td><td align="left" valign="top">3,484</td><td align="left" valign="top">3,568</td></tr><tr><td align="left" valign="top">5.7</td><td align="left" valign="top">9.0</td><td align="left" valign="top">50.7</td><td align="left" valign="top">50.3</td></tr></tbody></table></table-wrap></app><app id="appendix-2"><title>Appendix 2</title><table-wrap id="app2keyresource" position="anchor"><label>Appendix 2—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Pseudomonas aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib53">Stover et al., 2000</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa2541</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa2541</italic>∆<italic>pa2536</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa4323</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa4323</italic>∆<italic>pa4320</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114</italic>∆<italic>pa5113</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa2541, Tn7::AraE::pa2541</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa4323, Tn7::AraE::pa4323</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114, Tn7::AraE::pa5114</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa2541</italic>∆<italic>pa4323</italic>∆<italic>pa5114</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>gacS</italic> (∆<italic>pa0928</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>icmF1</italic> (∆<italic>pa0077</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Silverman et al., 2011</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5112</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114,</italic><italic>Tn7::AraE::</italic>empty</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114,</italic><italic>Tn7::AraE:: pfl_rs01995</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114,</italic><italic>Tn7::AraE:: i35_rs27920</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114, Tn7::AraE::pspto_rs26695</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114, Tn7::AraE::ta05_rs00690</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa3267</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>pa5114</italic>∆<italic>pa3267</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic> (∆<italic>pa4856</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Mougous et al., 2006</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic> ∆<italic>pa3267</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic> ∆<italic>pa5114</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>rpoS</italic> (∆<italic>pa3622</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Jørgensen et al., 1999</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>vacJ</italic> (∆<italic>pa2800</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Munguia et al., 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 <italic>pa2541</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic>, <italic>pa2541</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>gacS</italic>, <italic>pa2541</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 <italic>pa4323</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic>, <italic>pa4323</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>gacS</italic>, <italic>pa4323</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 <italic>pa5114</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic>, <italic>pa5114</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>gacS</italic>, <italic>pa5114</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="bottom">PAO1 ∆<italic>retS</italic>, <italic>pa5113</italic>_<italic>vsv-g</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Burkholderia thailandensis</italic>)</td><td align="left" valign="bottom">E264 (ATCC 700388)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib57">Yu et al., 2006</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 ∆<italic>icmF1</italic> (∆<italic>BTH_I2954</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">LeRoux et al., 2015a</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 <italic>tle3</italic><sup>S264A</sup>(<italic>BTH_II0090</italic><sup>S264A</sup> + <italic>BTH_I3226</italic><sup>S264A</sup>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 <italic>tle1</italic><sup>S267A</sup>(<italic>BTH_I2698</italic><sup>S267A</sup> + <italic>BTH_I2701</italic><sup>S267A</sup>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 ∆<italic>colA</italic> (∆<italic>BTH_I2691</italic>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 ∆<italic>tae2</italic> (∆<italic>BTH_I0068</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Russell et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 <italic>Tn7::Tp-PS12-mCherry</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib29">LeRoux et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom">E264 <italic>tle3 sensitized strain</italic> (∆<italic>BTH_I3225-8,</italic> ∆<italic>BTH_II0089-94</italic>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>B. thailandensis</italic>)</td><td align="left" valign="bottom"><italic>E264 Tn7::Tp-PS12-mCherry tle3 sensitized strain</italic> (∆<italic>BTH_I3225-8,</italic> ∆<italic>BTH_II0089-94</italic>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Pseudomonas protegens</italic>)</td><td align="left" valign="bottom">pf-5 (ATCC BAA-477)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Paulsen et al., 2005</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. protegens</italic>)</td><td align="left" valign="bottom"><italic>Pseudomonas protegens</italic> pf-5 ∆<italic>pfl_rs01995</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">DH5α</td><td align="left" valign="bottom">Thermo Fisher ScientificCat# 18258012</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">SM10</td><td align="left" valign="bottom">Biomedal Lifescience<break/>Cat# BS-3303</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">UE54MG1655 <italic>lpp-2Δara714 rcsF::mini-Tn10 cam pgsA::FRT-kan-FRT</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib17">Harvat et al., 2005</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa2541</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa2536</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa4323</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa4320</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa5114</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa5114/pa5113</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa3267</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa5113</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pa5112</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-∆<italic>pfl_rs01995</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-<italic>pa2541_vsv-g</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Construct to introduce VsvG tag, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-<italic>pa4323_vsv-g</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Construct to introduce VsvG tag, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-<italic>pa5114_vsv-g</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Construct to introduce VsvG tag, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEXG2-<italic>pa5113_vsv-g</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Construct to introduce VsvG tag, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE (plasmid)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib21">Hoang et al., 2000</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-pa2541 (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-pa4323 (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-<italic>pa5114</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-<italic>pfl_rs01995</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-<italic>i35_rs27920</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-<italic>pspto_rs26695</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18-Tn7t-pBAD-araE-<italic>ta05_rs00690</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Arabinose-inducible expression system, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pTNS3 (plasmid)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib5">Choi et al., 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-<italic>BTH_II0090</italic><sup>S264A</sup> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Point mutation construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-<italic>BTH_I3226</italic><sup>S264A</sup> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Point mutation construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-<italic>BTH_I2698</italic><sup>S267A</sup> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Point mutation construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-<italic>BTH_I2701</italic><sup>S267A</sup> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Point mutation construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-<italic>∆BTH_I2691</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-∆<italic>BTH_I3225-8</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pJRC115-∆<italic>BTH_II0089-94</italic> (plasmid)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Deletion construct, see Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUC18T-miniTn7T-Tp-PS12-mCherry (plasmid)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib29">LeRoux et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Construct for mCherry expression</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seqmagick</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Matsen Group, 2020</xref>, <ext-link ext-link-type="uri" xlink:href="https://github.com/fhcrc/seqmagick">https://github.com/fhcrc/seqmagick</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">TRANSIT TPP</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://transit.readthedocs.io/en/latest/tpp.html">https://transit.readthedocs.io/en/latest/tpp.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VSV-G (rabbit polyclonal)</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">Cat# V4888-200UG</td><td align="left" valign="bottom">Western blot (1:5000 dilution)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG HRP conjugated (goat)</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">Cat# A6154-1ML</td><td align="left" valign="bottom">Western blot (1:5000 dilution)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ribosome polymerase β (mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 663903; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2564524">AB_2564524</ext-link></td><td align="left" valign="bottom">Western blot (1:1000 dilution)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG HRP conjugated (sheep)</td><td align="left" valign="bottom">MilliporeSigma</td><td align="left" valign="bottom">Cat# AC111P</td><td align="left" valign="bottom">Western blot (1:4000 dilution)</td></tr></tbody></table></table-wrap></app><app id="appendix-3"><title>Appendix 3</title><table-wrap id="app3table1" position="float"><label>Appendix 3—table 1.</label><caption><title>Oligonucleotides used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Oligonucleotides 5′–3′</th><th align="left" valign="bottom">Source</th></tr></thead><tbody><tr><td align="left" valign="bottom">pEXG2_∆PA2541_F1CAAGCTTCTGCAGGTCGACTCTAGAAGGTGGAACCGGACCTGAAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2541_R1CTCAGGCCTGGGAAATCATGTCAGCCAGTCC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2541_F2CATGATTTCCCAGGCCTGAGAGGGAACG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2541_R2TAAGGTACCGAATTCGAGCTCGTATGACCCAGGCGGTCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4323_F1AGCTCGAGCCCGGGGATCCTCTAGAGACGCAGAACCCGATCGAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4323_R1AAAGCACGCCCGATGGCTTCATACGCGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4323_F2GAAGCCATCGGGCGTGCTTTGACGGATC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4323_R2GGAAGCATAAATGTAAAGCAAGCTTGAGCGATGCCGAGCTGGA</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114_F1CAAGCTTCTGCAGGTCGACTCTAGAGCCGCATGCCCTTGACCT</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114_R1CGACCTCGGCAATCCATTGCATGCGTCGAATC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114_F2GCAATGGATTGCCGAGGTCGCATCGGAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114_R2AATTCGAGCTCACCAGATCATCGGCGCCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2536_F1CAAGCTTCTGCAGGTCGACTCTAGACTCGGCCTGGCCCGAGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2536_R1CAGGCGAACCTCAGGGCGTTTCGTTCATCTCAGGCCTCC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2536_F2GGAGGCCTGAGATGAACGAAACGCCCTGAGGTTCGCCTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA2536_R2TAAGGTACCGAATTCGAGCTCCACATCGGTCTCAGCGAAGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4320_F1AGCTCGAGCCCGGGGATCCTCTAGATGTTCGGCTTCTACATCATGAAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4320_R1TGCGCCAGCCCACGCTGGCGTCAGTCAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4320_F2CGCCAGCGTGGGCTGGCGCAGCCTTTTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA4320_R2GGAAGCATAAATGTAAAGCAAGCTTGTCGGCGGTTTCCTCGCT</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114/PA5113_F1CAAGCTTCTGCAGGTCGACTCTAGAGCCGCATGCCCTTGACCT</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114/PA5113_R1TGTTCGGCGAAATCCATTGCATGCGTCGAATC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114/PA5113_F2GCAATGGATTTCGCCGAACAAGCCATGAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5114/PA5113_R2TAAGGTACCGAATTCGAGCTCAACAGCCAGACCACGATGTAGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5113_F1CAAGCTTCTGCAGGTCGACTCTAGATTGCTAGGGGTGCTGGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5113_R1ATGGCTTGTTGGAGCGCGTCATGGCTGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5113_F2GACGCGCTCCAACAAGCCATGAGCCGGTTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5113_R2TAAGGTACCGAATTCGAGCTCAACAGCCAGACCACGATGTAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5112_F1CAAGCTTCTGCAGGTCGACTCTAGATACCGCTGGCAGTTGCCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5112_R1AGAAGTCCAGCGCCATTCTGATCATTCTCTTACTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5112_F2CAGAATGGCGCTGGACTTCTGAAACGGCGGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA5112_R2TAAGGTACCGAATTCGAGCTCCGCGCAACCGCCGGTTGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA3267_F1CAAGCTTCTGCAGGTCGACTCTAGATCTACATCGACTTCGACG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA3267_R1ATCAGCGAGCTTGGGTCATCGTCCTTGTTAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA3267_F2GATGACCCAAGCTCGCTGATCGATCCGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PA3267_R2TAAGGTACCGAATTCGAGCTCTTCGCCGGCCTGTTCGAAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PFL_RS01995_F1CAAGCTTCTGCAGGTCGACTCTAGAAACTACAACGTCAGCCTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PFL_RS01995_R1TTCATTCAACGGTTTGCCTATCCATTGCATGTGTCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PFL_RS01995_F2CGACACATGCAATGGATAGGCAAACCGTTGAATGAA</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_∆PFL_RS01995_R2TAAGGTACCGAATTCGAGCTCCTGCGACCACACCAGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA2541_VSVG_F1CAAGCTTCTGCAGGTCGACTCTAGAGCGCTGATACGGACCATGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA2541_VSVG_R1TTTTCCTAATCTATTCATTTCAATATCTGTATAGGCCTGGCCGTCGCTGCCCCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA2541_VSVG_F2TATACAGATATTGAAATGAATAGATTAGGAAAATGAGAGGGAACGGGCGAAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA2541_VSVG_R2TAAGGTACCGAATTCGAGCTCCTCCTGCGGCGCACGATG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA4323_VSVG_F1CAAGCTTCTGCAGGTCGACTCTAGATGGAGTTCCACCAGTTGCGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA4323_VSVG_R1TGATCCGTCATTTTCCTAATCTATTCATTTCAATATCTGTATAAAGCACGCCGGCGCGCT</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA4323_VSVG_F2TATACAGATATTGAAATGAATAGATTAGGAAAATGACGGATCAGACCGACTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA4323_VSVG_R2TAAGGTACCGAATTCGAGCTCAAGGTACACTTCTCCGCC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5114_VSVG_F1CAAGCTTCTGCAGGTCGACTCTAGACTGGAGCTGCGCTACCTGTTCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5114_VSVG_R1TAATCTATTCATTTCAATATCTGTATATGGCTGCTCGGCCTCCGA</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5114_VSVG_F2GATATTGAAATGAATAGATTAGGAAAATCGGAGGCCGAGCAGCCA</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5114_VSVG_R2TAAGGTACCGAATTCGAGCTCGCTCGGACCAGATCATCGGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5113_VSVG_F1CAAGCTTCTGCAGGTCGACTCTAGACTGCGTCTGGCCTGGCCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5113_VSVG_R1TTTTCCTAATCTATTCATTTCAATATCTGTATATGGCTTGTTCGGCGAGGAAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5113_VSVG_F2TATACAGATATTGAAATGAATAGATTAGGAAAATGAGCCGGTTCCGCGCTATG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pEXG2_PA5113_VSVG_R1TAAGGTACCGAATTCGAGCTCGTCGGGCAACAGCCAGAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA2541_FAGC GAATTCGAGCTCGGTACCACGGGAGGAAAG ATGATTTCCGTCTATCAACTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA2541_RCTCATCCGCCAAAACAGCCAAGCTTTCAGGCCTGGCCGTCGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA4323_FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGAAGCCATCGCGCGCCCTGCTGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA4323_RCTCATCCGCCAAAACAGCCAAGCTTTCAAAGCACGCCGGCGCGCTTCCAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA5114_FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGCAATGGATTTTCATGCTGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_PA5114_RCTCATCCGCCAAAACAGCCAAGCTTTCATGGCTGCTCGGCCTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>pfl_rs01995</italic>_FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGCAATGGATATTCATGCTGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>pfl_rs01995</italic>_RCTCATCCGCCAAAACAGCCAAGCTTTCACGATGACACTCCTTCATTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>i35_rs27920</italic>_FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGAACTGGGCATTCGCCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>i35_rs27920</italic>_RCTCATCCGCCAAAACAGCCAAGCTTTCATGGCTGGCCGTCCTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>pspto_rs26695</italic>_FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGCTTTGGATTTGTCTGGTAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>pspto_rs26695</italic>_RCTCATCCGCCAAAACAGCCAAGCTTTCATGGCGTTTCAGGCGCTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>ta05_rs00690_</italic>FAGCGAATTCGAGCTCGGTACCACGGGAGGAAAGATGGACGACCTTTTAATCCTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pUC18_<italic>ta05_rs00690_</italic>RCTCATCCGCCAAAACAGCCAAGCTTTCATTTGTTTTCTCCAGCTTTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_II0090</italic><sup>S264A</sup>_F1TAAAACGACGGCCAGTGCCAAGCTTCGACGGATCAGCGTTTCAAGCTGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_II0090</italic><sup>S264A</sup>_R1ACCTTGGGCATGACCCATCACCGTGATCGTTTCGTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_II0090</italic><sup>S264A</sup>_F2GGTCATGCCCAAGGTACGATCATCACGCTGCTCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_II0090</italic><sup>S264A</sup>_R2GCTCGGTACCCGGGGATCCTCTAGACGGCTCGGCACGATGCGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I3226</italic><sup>S264A</sup>_F1TAAAACGACGGCCAGTGCCAAGCTTCGACGGATCAGCGTTTCAAGCTGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I3226</italic><sup>S264A</sup>_R1ACCTTGGGCATGACCCATCACCGTGATCGTTTCGTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I3226</italic><sup>S264A</sup>_F2GGTCATGCCCAAGGTACGATCATCACGCTGCTCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I3226</italic><sup>S264A</sup>_R2GCTCGGTACCCGGGGATCCTCTAGACGGCTCGGCACGATGCGC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2698</italic><sup>S267A</sup>_F1TCAATCAGTATCTAGAGGGACACCTTTCTCAAGCGAAATC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2698</italic><sup>S267A</sup>_R1GCCGCGCGCGAAACCAAACACATAAAGGCGAATGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2698</italic><sup>S267A</sup>_F2GGTTTCGCGCGCGGCGCAGCGGAAGCTCGCACGTTTTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2698</italic><sup>S267A</sup>_R2TGTTAAGCTAGAATTCCATCAAACCCGCTGTCCCATGCTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2701</italic><sup>S267A</sup>_F1TAAAACGACGGCCAGTGCCAAGCTTGAAAGACGAGCAGGACGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2701</italic><sup>S267A</sup>_R1ACCCCGCGCGAAACCGAATACGTATAGCCGAATGCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2701</italic><sup>S267A</sup>_F2GGTTTCGCGCGGGGTGCAGCGGAGGCTCGCAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ <italic>BTH_I2701</italic><sup>S267A</sup>_R2GCTCGGTACCCGGGGATCCTCTAGACTCGACCTCCAGCAGATCG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I2691</italic>_F1TAAAACGACGGCCAGTGCCAAGCTTATTTCAAGCGCGGCCAGTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I2691</italic>_R1ATCTATGCGAGCTTCCCGCCATTTTTATTCC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I2691</italic>_F2GGCGGGAAGCTCGCATAGATGAGTGATG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I2691</italic>_R2GCTCGGTACCCGGGGATCCTCTAGATTCTGTCAATACTTAAAATACAATTTTC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_II0089-94</italic>_F1TAAAACGACGGCCAGTGCCAAGCTTGAATCAGTGCATCGCTGTAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_II0089-94</italic>_R1ATGTTTTGCTTAGCGTATCGTTCAAATTGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_II0089-94</italic>_F2CGATACGCTAAGCAAAACATGAGATTATTGAAGAG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_II0089-94</italic>_R2GCTCGGTACCCGGGGATCCTCTAGATATGCAACGCATTGCCGAAAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I3225-8</italic>_F1TAAAACGACGGCCAGTGCCAAGCTTCCGGTCAATATACCACCATC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I3225-8</italic>_R1ATGTGCGCCCCGTATCGTTCAAATTGGTCAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I3225-8</italic>_F2GAACGATACGGGGCGCACATAATAAGACTTG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">pJRC115_ ∆<italic>BTH_I3225-8</italic>_R2GCTCGGTACCCGGGGATCCTCTAGAATTTGCTGTTTCTGCTGATG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">PCR_1AGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGGGGGGGGGGGGGGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">PCR_1BTCATCGGCTCGTATAATGTGTGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">PCR_2ACAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">PCR_2BCAAGCAGAAGACGGCATACGAGATCTAGTACGGTCTCGTGGGCTCGG</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">PCR_2CAATGATACGGCGACCACCGAGATCTACACCTAGAGACCGGGGACTTATCAGCCAACCTGTTA</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom">Seq_primerCTAGAGACCGGGGACTTATCAGCCAAC</td><td align="left" valign="bottom">Integrated DNA Technology</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74658.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mignot</surname><given-names>Tâm</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS-Aix Marseille University</institution></institution-wrap><country>France</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.08.22.457286" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.22.457286"/></front-stub><body><p>This study identifies novel (Arc) pathways that mediate resistance of bacteria to attacks by other bacteria. The identified genes appear to specifically protect host cells from the action of bacterial toxins. In particular, one system (Arc3) is shown to protect <italic>Pseudomonas aeruginosa</italic> from Type-6 secretion phospholipase effectors. Thus, while it is growing increasingly clear that bacteria have evolved numerous protection mechanisms against phages, the study expands this concept to bacteria.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74658.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mignot</surname><given-names>Tâm</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS-Aix Marseille University</institution></institution-wrap><country>France</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Sogaard-Andersen</surname><given-names>Lotte</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05r7n9c40</institution-id><institution>Max Planck Institute for Terrestrial Microbiology</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.22.457286">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.08.22.457286v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Coordinately regulated interbacterial antagonism defense pathways constitute a bacterial innate immune system&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Wendy Garrett as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Lotte Sogaard-Andersen (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor with input from the senior editor. Consensus was that the manuscript is of significant import and interest but will require revision. We have drafted this document to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors define the arc1-arc3 genes as part of a &quot;bacterial innate immune system&quot;. This should be toned down, because it is not proven that they allow self- vs non-self-discrimination. In fact, the heterologous expression of Arc3B protects as well in Pa (presumably even Arc3B encoded in a B. thai) which argues against true self -vs non-self-discrimination.</p><p>2) The protective function of Arc3B could be further clarified: does it act directly on Tle3 or indirectly via a converging pathway that removes LPE or MLCL or acts on them? While it is understood that defining the exact molecular function of Arc3B is beyond the immediate scope of this manuscript, it should be possible to discriminate, testing for example if Arc3B can can protect against another phospholipase or whether LPE/MCL levels can be affected by Arc3B independently of Tle3. And last, does Arc3B require Arc3A for activity?</p><p>3) The manuscript is densely written and should be edited to make it an easier read for a broad audience.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. line 126: Arc1 inactivation is described as resulting in a modest reduction in B. thai survival. My reading of the figure is that Arc1 inactivation results in a modest increase in B. thai survival. Please clarify.</p><p>2. line 126-127: I do not understand these comparisons. Maybe explain in a bit more detail.</p><p>3. Figure 2B: What is plotted on the Y-axis?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors define the arc1-arc3 genes as part of a &quot;bacterial innate immune system&quot;. I found this choice questionable since it is not proven that they allow self- vs non-self-discrimination. In fact, since heterologous expression of Arc3B can protect as well in Pa (presumably even Arc3B encoded in a B. thai), it's not a true self -vs non-self-discrimination. Would referring to it as an antitoxin not be suitable instead?</p><p>The underpinnings protective (antitoxin) effect of Arc3B remain murky: does it fulfill a structural role, perhaps sequestering Tle3 or interfering with its activity, stability or translocation? Or does it act via a converging pathway that removes LPE or MLCL or acts on them, in parallel to Aas? In the latter case, Arc3B should be possible to protect against phospholipid cleavage caused in other ways than Tle3-mediated intoxication. Can this be tested with another phospholipase for example (expressed in Pa for self-intoxication)? The authors have not shown that LPE and MLCL levels can be modulated by Arc3B (with or without Arc3A) in the absence of Tle3, begging the question whether Arc3B acts specifically on Tle3 or phospholipase-mediated damage in general. Conversely can Aas overexpression compensate for loss of Arc3B and/or Arc3A in response to Tle3 intoxication?</p><p>Were the Arc3B orthologs that were chosen for complementation only from species that encode Arc3A or also from those that encode a solitary Arc3B? This could be discussed.</p><p>Arc3B interacts with Arc3A, but it does not appear to have enzymatic activity. It would be useful to know if Arc3B requires Arc3A for activity (assessed by epistasis experiments using Arc3B/A single and double mutants). One would predict that Arc3B can act independently of Arc3A since Arc3A is not always co-conserved with Arc3B, in which case the association between Arc3A and Arc3B should not be important to protect against Tle3.</p><p>Line 111 and panel A with B of Figure1—figure supplement 3: I don't see the cumulative effect claimed when compared the triple mutant Δarc123 (panel A) to single deletions (panel B).</p><p>Figure 1—figure supplement 3A: the names of the deleted strains seem incorrect: Δarc1DΔarc1G should be Δarc2DΔarc2G; as well Δarc1AΔarc1B is Δarc3AΔarc3B.</p><p>Line 218: Protection by Arc3A is valid for Tle3 and not against Tle1 (that is also a phospholipase). Change &quot;against interbacterial phospholipase toxins&quot; to &quot;against Tle3 interbacterial phospholipase toxin&quot;.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74658.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors define the arc1-arc3 genes as part of a &quot;bacterial innate immune system&quot;. This should be toned down, because it is not proven that they allow self- vs non-self-discrimination. In fact, the heterologous expression of Arc3B protects as well in Pa (presumably even Arc3B encoded in a B. thai) which argues against true self -vs non-self-discrimination.</p></disp-quote><p>We thank the reviewer(s) for raising this matter. One possibility here is that the reviewer(s) may misunderstand how producers of Tle3 (such as <italic>B. thailandensis</italic>) prevent self-intoxication. These organisms do not rely on Arc3A homologs to provide protection; indeed, <italic>B. thai</italic> lacks a discernable homolog of <italic>arc3A</italic> and we generally see no correlation between the presence of <italic>arc3A</italic> homologs and predicted phospholipase toxin genes across bacterial genomes<italic>.</italic> Rather, self-intoxication is prevented (with 100% efficacy) through the production of dedicated immunity proteins encoded adjacent to the effector genes.</p><p>Additionally, we note that in eukaryotic innate immune systems, discrimination between self and non-self typically involves a means of sensing the foreign invader coupled to induction of protective responses. In <italic>P. aeruginosa,</italic> production of Arc3A is controlled by the Gac/Rsm globally regulatory system, and we show that this is associated with low expression of Arc3A during pure culture growth (Figure 2—figure supplement 2). Previously, we demonstrated that the Gac/Rsm pathway is activated specifically by the presence of an antagonistic competitor, via the lysis of a subset of the population and release of an as yet unidentified cellular component that serves as the activating signal (LeRoux <italic>et al.</italic>, 2015. <italic>eLife</italic>). Thus, paralleling eukaryotic innate immune system effectors, Arc3A becomes activated only under conditions where a foreign threat is perceived.</p><p>Finally, we would respectfully disagree with the assertion that self-vs. non-self discrimination is the sole function of an immune system. A key function of the eukaryotic innate immune system is the detection of and response to damaged cells (Kono and Rock, 2008. <italic>Nat. Rev. Microbiol.</italic>). This occurs through the detection of so-called danger associated molecular patterns (DAMPs), which can be generated either through the action of foreign invaders or self-derived sources of cellular damage (Shi <italic>et al.,</italic> 2003 <italic>Nature;</italic> Martinon <italic>et al.</italic>, 2006. <italic>Nature</italic>).</p><p>However, these considerations aside, at the reviewers’ request, we have toned down the language we use to describe the pathways we have discovered in both the discussion (p15, line 390) and the title of the paper (now modified to “Discovery of coordinately regulated pathways that provide innate protection against interbacterial antagonism”).</p><disp-quote content-type="editor-comment"><p>2) The protective function of Arc3B could be further clarified: does it act directly on Tle3 or indirectly via a converging pathway that removes LPE or MLCL or acts on them? While it is understood that defining the exact molecular function of Arc3B is beyond the immediate scope of this manuscript, it should be possible to discriminate, testing for example if Arc3B can can protect against another phospholipase or whether LPE/MCL levels can be affected by Arc3B independently of Tle3. And last, does Arc3B require Arc3A for activity?</p></disp-quote><p>We agree that it would be of interest to further clarify the protective function of Arc3A. We have attempted numerous experiments in an attempt to determine whether Arc3A can provide protection against other phospholipases, but have been met with a number of technical challenges. <italic>B. thailandensis</italic> produces a second phospholipase effector, Tle1. This protein has a less significant impact on <italic>P. aeruginosa</italic> growth than Tle3, but by reducing <italic>P. aeruginosa</italic> defenses through inactivation of the T6SS in this organism, we were able to detect a small but significant level of inhibition attributable to Tle1 (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) . Inactivation of Ar3A under these conditions did not further sensitize <italic>P. aeruginosa</italic> to the activity of Tle1. However, a key caveat of this experiment is that the impact of Arc3A on Tle1-mediated intoxication in these assays may be masked by the stronger effect of Tle3. A “publishable” experiment would involve inactivating Tle3 to isolate the effect of Tle1-mediated intoxication. However, two homologous but non-identical copies of both <italic>tle3</italic> and <italic>tle1</italic> are encoded in <italic>B. thai</italic>, and generating the quadruple mutant necessary to perform this experiment in a controlled fashion has proved technically challenging. A second avenue we have explored is to evaluate whether inactivation of Arc3A results in sensitivity to other antagonists that encode known or predicted phospholipase toxins. Inactivation of Arc3A failed to sensitize <italic>P. aeruginosa</italic> to intoxication by six different phospholipase-encoding strains from five species. However, we are not confident in the interpretation of this result because each of the toxin-producing strains employed is significantly out-competed by <italic>P. aeruginosa</italic>, even when the experiment is initiated at a high donor:recipient ratio (, see strongly negative C.I. values), which is perhaps not surprising given the extensive offensive and defense arsenal this organism can employ. Thus, we have been unable to conclusively evaluate whether Arc3A confers protection against additional lysophospholipid-generating toxins.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Inactivation of Arc3A does not detectably impact <italic>P. aeruginosa</italic> growth in competition with assorted phospholipase producing species.</title><p>(<bold>A</bold>) Recovery of <italic>P. aeruginosa</italic> with the indicated genotypes following growth in competition with an excess of wild-type or Tle1-inactivated <italic>B. thai.</italic> (<bold>B and C</bold>) Recovery of <italic>P. aeruginosa</italic> (<bold>B</bold>) or competitive index obtained (<bold>C</bold>; final donor:recipicient ratio divided by initial donor:recipienct ratio) following growth in competition with the indicated organisms.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74658-sa2-fig1-v2.tif"/></fig><p>To evaluate whether Arc3A can affect LPE levels in the absence of Tle3, we have isolated spheroplasts of <italic>P. aeruginosa</italic> expressing Arc3A or a derivative in which <italic>arc3A</italic> is deleted and incubated these with radiolabeled LPE. We find that Arc3A does not significantly affect the rate of LPE degradation in this assay (Figure 4G). This result was included but not highlighted in the original manuscript. We have now added mention of this finding to the results (p. 14, lines 365-366).</p><p>Finally, while our Tn-seq results indicate that Arc3B contributes to <italic>P. aeruginosa</italic> competitiveness, in pairwise competition experiments we see no evidence that Arc3B is required for Arc3A activity. This finding is now incorporated into the revised manuscript (<italic>revised</italic> Figure 3—figure supplement 1 and p12, lines 267-276). Arc3B is encoded downstream of Arc3A, suggesting the difference in phenotype we observed between the two assays is not due merely to polar effects of transposon insertion. Of note, we also found that transposon insertions in <italic>aas</italic> were associated with reduced <italic>P. aeruginosa</italic> fitness under the conditions of our tn-seq screen, but similarly, deletion of this gene did not have an effect on competitiveness in pairwise competitions. These findings suggest the transposon screen represents a more sensitive assay for the detection of genes important for fitness during interbacterial competition, and thus that Arc3B plays an important but auxiliary role in <italic>P. aeruginosa</italic> defense against antagonism.</p><disp-quote content-type="editor-comment"><p>3) The manuscript is densely written and should be edited to make it an easier read for a broad audience.</p></disp-quote><p>We regret any difficulty that our writing style may have caused and we thank the reviewer for providing this comment. We have incorporated revisions throughout the manuscript to improve readability:</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. line 126: Arc1 inactivation is described as resulting in a modest reduction in B. thai survival. My reading of the figure is that Arc1 inactivation results in a modest increase in B. thai survival. Please clarify.</p></disp-quote><p>The reviewer is correct in that inactivation of Arc1 causes a modest increase in <italic>B. thai</italic> survival, i.e. a modest decrease in the ability of <italic>P. aeruginosa</italic> ability to kill <italic>B. thai.</italic> We regret the confusion caused by our original statement and have revised for clarity (p8, lines 143-145).</p><disp-quote content-type="editor-comment"><p>2. Line 126-127: I do not understand these comparisons. Maybe explain in a bit more detail.</p></disp-quote><p>We have revised the description of these experiments to provide more clarity (p. 7, line 131-p. 8, line 145)</p><disp-quote content-type="editor-comment"><p>3. Figure 2B: What is plotted on the Y-axis?</p></disp-quote><p>The specific metric presented in this figure was calculated by dividing the <italic>P. aeruginosa</italic> CFUs obtained for the indicated mutant by those obtained for the wild-type strain during competition with the indicated <italic>B. thai</italic> strain, and then multiplying by 100 to obtain a percentage. We have revised the figure legend to make this more clear.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors define the arc1-arc3 genes as part of a &quot;bacterial innate immune system&quot;. I found this choice questionable since it is not proven that they allow self- vs non-self-discrimination. In fact, since heterologous expression of Arc3B can protect as well in Pa (presumably even Arc3B encoded in a B. thai), it's not a true self -vs non-self-discrimination. Would referring to it as an antitoxin not be suitable instead?</p></disp-quote><p>See the response to Essential Revision #1 above.</p><disp-quote content-type="editor-comment"><p>The underpinnings protective (antitoxin) effect of Arc3B remain murky: does it fulfill a structural role, perhaps sequestering Tle3 or interfering with its activity, stability or translocation? Or does it act via a converging pathway that removes LPE or MLCL or acts on them, in parallel to Aas? In the latter case, Arc3B should be possible to protect against phospholipid cleavage caused in other ways than Tle3-mediated intoxication. Can this be tested with another phospholipase for example (expressed in Pa for self-intoxication)? The authors have not shown that LPE and MLCL levels can be modulated by Arc3B (with or without Arc3A) in the absence of Tle3, begging the question whether Arc3B acts specifically on Tle3 or phospholipase-mediated damage in general. Conversely can Aas overexpression compensate for loss of Arc3B and/or Arc3A in response to Tle3 intoxication?</p></disp-quote><p>We agree with the reviewer that a mechanistic explanation for the protected effect of Arc3B remains unclear. From an evolutionary perspective, it seems unlikely that Arc3A acts specifically to provide defense against one phospholipase toxin produced by another species. However, for technical reasons discussed above (see Essential Revision #2), we have yet to identify other phospholipase-targeting toxins against which Arc3A conclusively provides protection. As requested by the reviewer, we have evaluated whether Aas over-expression can compensate for Arc3A inactivation. Our data show that Aas over-expression does not alter the compromised defense of ∆<italic>arc3A</italic> (<italic>new</italic> Figure 4—figure supplement 3 and p14, lines 362-364)<bold>.</bold></p><disp-quote content-type="editor-comment"><p>Were the Arc3B orthologs that were chosen for complementation only from species that encode Arc3A or also from those that encode a solitary Arc3B? This could be discussed.</p></disp-quote><p>The Arc3A homologs we evaluated for their ability to complement the <italic>arc3A</italic> deletion in <italic>P. aeruginosa</italic> were all from organisms that also encoded a homolog of Arc3B. The organisms encoding unaccompanied Arc3A homologs are all distantly related to <italic>P. aeruginosa</italic> (Gram-positives, cyanobacteria, etc., see Figure 3B) and thus we reasoned that poor expression of the genes would confound the experiment.</p><disp-quote content-type="editor-comment"><p>Arc3B interacts with Arc3A, but it does not appear to have enzymatic activity. It would be useful to know if Arc3B requires Arc3A for activity (assessed by epistasis experiments using Arc3B/A single and double mutants). One would predict that Arc3B can act independently of Arc3A since Arc3A is not always co-conserved with Arc3B, in which case the association between Arc3A and Arc3B should not be important to protect against Tle3.</p></disp-quote><p>The prediction of the reviewer is correct, in that Arc3B is not required for Ar3A activity. In the revised manuscript, we include the results of the suggested experiment, which demonstrates that inactivation of Arc3B alone or in combination with Arc3A does not affect <italic>P. aeruginosa</italic> competitiveness in pairwise competition assays with <italic>B. thailandensis</italic> (<italic>revised</italic> Figure 3—figure supplement 1 and p12, lines 267-276)<italic>.</italic> However, we note that in our Tn-seq assays, <italic>arc3A</italic> was depleted more than 3-fold following competition with antagonistic <italic>B. thailandensis</italic>. Importantly, <italic>arc3A</italic> is encoded downstream of <italic>arc3B</italic>, thus eliminating the possibility that this phenotype results from polar effects of the transposon. Thus, it appears that Arc3A does contribute to competitiveness under some conditions, but is clearly not required for Arc3B function in <italic>P. aeruginosa</italic>.</p><disp-quote content-type="editor-comment"><p>Line 111 and panel A with B of Figure1—figure supplement 3: I don't see the cumulative effect claimed when compared the triple mutant Δarc123 (panel A) to single deletions (panel B).</p></disp-quote><p>The cumulative effect we are referring to here is apparent when comparing the parental final CFU counts to those of the individual mutants or the triple mutant for a given experiment. We observe a degree of variability in the growth yield of the parent strain competed against <italic>B. thai</italic> in different experiments. To highlight the difference we are referring to, we have now added the fold difference value for CFUs obtained for the mutants vs. the parent strain to each graph (revised Figure 1—figure supplement 3).</p><disp-quote content-type="editor-comment"><p>Figure 1—figure supplement 3A: the names of the deleted strains seem incorrect: Δarc1DΔarc1G should be Δarc2DΔarc2G; as well Δarc1AΔarc1B is Δarc3AΔarc3B.</p></disp-quote><p>The reviewer is correct and we have fixed this error in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Line 218: Protection by Arc3A is valid for Tle3 and not against Tle1 (that is also a phospholipase). Change &quot;against interbacterial phospholipase toxins&quot; to &quot;against Tle3 interbacterial phospholipase toxin&quot;.</p></disp-quote><p>We appreciate the issue raised here. We have revised this sentence to indicate more clearly that we currently only have evidence for protection against one type of phospholipase toxin provided by Arc3A (p 12, line 266).</p></body></sub-article></article>